EurekaMag PDF full texts Chapter 33,284

Feletou, M.; Robineau, P.; Lonchampt, M.; Bonnardel, E.; Thurieau, C.; Fauchere, J.L.c; Widdowson, P.; Mahieu, J.P.erre; Serkiz, B.; Volland, J.P.ul; Martin, C.; Naline, E.; Advenier, C.; Prost, J.F.ancois; Canet, E. 1995: S 16118 bradykinin is a potent and long-acting bradykinin B-2 receptor antagonist, in vitro and in vivo. Journal of Pharmacology and Experimental Therapeutics 273(3): 1071-1077

Millan, M.J.; Audinot, V.; Brocco, M.; Maurel Remy, S.; Joly, F.; Newman Tancredi, A.; Canton, H.; Hautefaye, P.; Spedding, M.; Muller, O.; Lavielle, G. 1994: S 16924 A pyrrolidine-substituted benzodioxane with higher affinity at 5-HT-1A/2A/2C than D-2 receptors, and an atypical antipsychotic profile in the rat. British Journal of Pharmacology 114(Proceedings Suppl ): 156P

Cordi, A.A.; Duhault, J.; Laudignon, N.; Catagne, I. 1996: S 16961-1 Hypolipidemic. Drugs of the Future 21(5): 490-492

Morain, P.; Lestage, P.; Roger, A.; Bobichon, C.; Desos, P.; Cordi, A.; Lepagnol, J. 1994: S 17625, a selective and competitive non-NMDA antagonist Cerebral anti-ischaemic effects in rodents. British Journal of Pharmacology 114(Proceedings Suppl ): 330P

Peglion, J.L.; Audinot, V.; Brocco, M.; Bervoets, K.; Daquet, C.; Newman Tancredi, A.; Canton, H.; Millan, M.J. 1994: S 17828 and S 14956, novel benzisoxazoles displaying antipsychotic properties and a low side-effect profile in animal models A comparison to risperidone. Society for Neuroscience Abstracts 20(1-2): 1773

Millan, M.J.; Newman Tancredi, A.; Audinot, V.; Brocco, M.; Gobert, A.; Rivet, J.M.; Peglion, J.L. 1996: S 18126, a novel, potent and selective antagonist at human recombinant dopamine hD-4 receptors. Society for Neuroscience Abstracts 22(1-3): 1772

Millan, M.J.; Audinot, V.; Newman Tancredi, A.; Dekeyne, A.; Gobert, A.; Lochon, S.; Rivet, J.M.; Goument, B.; Peglion, J.L. 1998: S 18127 A novel and selective, aminopiperidine antagonist at serotonin 1B/1D receptors. Society for Neuroscience Abstracts 24(1-2): 1364

Verbeuren, T.J.; Vayssettes Courchay, C.; Descombes, J.J.; Simonet, S.; Lacoste, J.M.; Cordi, A.; Laubie, M. 1996: S 18149 is a partial agonist at alpha-adrenoceptors Studies in pithed rats and isolated canine and human blood vessels. British Journal of Pharmacology 117(Proceedings Suppl ): 277P

Millan, M.J.; Newman Tancredi, A.; Audinot, V.; Despaux, N.; Peglion, J.L. 1997: S 18327, a novel, phenylimidazolinone antipsychotic agent I Receptor profile in comparison to haloperidol, clozapine, seroquel and olanzapine. Society for Neuroscience Abstracts 23(1-2): 1930

Gobert, A.; Peglion, J.L.; Brocco, M.; Rivet, J.M.; Schreiber, R.; Monneyron, S.; Cistarelli, L.; Despaux, N.; Millan, M.J. 1997: S 18327, a novel, phenylimidazolinone antipsychotic agent II Functional profile in comparison to haloperidol, clozapine, seroquel and olanzapine. Society for Neuroscience Abstracts 23(1-2): 1931

Millan, M.J.; Bervoets, K.; Girardon, S.; Gobert, A.; Newman Tancredi, A.; Audinot, V.; Rivet, J.M.; Lacoste, J.M.; Cordi, A. 1995: S 18616 A potent, high efficacy and selective spiroimidazoline agonist at alpha-2-adrenergic receptors. Society for Neuroscience Abstracts 21(1-3): 1416

Lockhart, B.; Iop, F.; Bonhomme, N.; Lestage, P. 1998: S 18986-1, a new positive modulator of AMPA-type glutamate receptors, potentiates AMPA-mediated -noradrenaline release from rat hippocampal slices. Society for Neuroscience Abstracts 24(1-2): 98

Lebrun, C.; Roger, A.; Pilliere, E.; Albinet, K.; Krentner, M.; Lestage, P. 1998: S 18986-1, positive modulator of AMPA-type glutamate receptors, a novel cognitive enhancing agent. Society for Neuroscience Abstracts 24(1-2): 98

Descombes, J.J.; Menant, Y.; Barou, V.; Cordi, A.; Verbeuren, T.J. 1998: S 19014 is a partial agonist at alpha-adrenoceptors that selectively contracts the veins. Pharmacology and Toxicology 83(Suppl 1): 92

Harris, T.M. 1983: S 2 r 8 r 8a r 1 2 8 tri hydroxy octa hydro indolizine swainsonine an alpha mannosidase inhibitor from rhizoctonia leguminicola. Tetrahedron: 29-32

Martinet, L.; Serviere, J.; Mocaer, E. 1995: S 20098, a melatonin agonist, entrains rat circadian activity rhythms in a dose and plasmatic concentration dependent manner. Society for Neuroscience Abstracts 21(1-3): 182

Anon 1989: S 26308. Drugs of the Future 14(9): 870-871

Hashimoto, A.; Ichimoto, I. 1990: S 3 acetyl 1 2 diacyl sn glycerols from the lipids of drosicha corpulenta kuwana homoptera margarodidae. Applied Entomology and Zoology 25(4): 515-516

Bronson J.J.; Ho H T.; De Boeck H.; Woods K.L.; Ghazzouli I.; Yang H.; Klunk L.J.; Russell J.W.; Whiterock V.J.; Datema R.; Martin J.C.; Hitchcock M.J.M. 1990: S 3 hydroxy 2 phosphonylmethoxypropylcytosine hpmpc studies on intracellular metabolism and the effect of infrequent dosing on antiviral efficacy. Antiviral Research (Suppl 1): 111

Hropot, M.; Schwark, J.R.; Jansen, H.W.; Langer, K.H.; Lang, H.J.; Busch, A. 1998: S 3226, a novel NHE 3 blocker, attenuated ischemia-induced acute renal failure in rats. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 578A

Downes, T.R.; Nomeir, A.M.; Little, W.C. 1990: S 4 gallop predicts the doppler pattern of left ventricular diastolic filling. Clinical Research 38(1): 25A

Rabasseda, X.; Mealy, N.; Castaner, J. 1995: S 4661. Drugs of the Future 20(4): 367-370

Elfarra, A.A.; Hwang, I.Y. 1989: S 6 purinyl l cysteine pc a cysteine conjugate beta lyase activated prodrug of 6 mercaptopurine. FASEB Journal 3(3): A427

Chu, D.T.; Rosen, T.J. 1989: S 7 3 aminopyrrolidin 1 yl 1 o p difluorophenyl 1 4 dihydro 6 fluoro 4 oxo 1 8 naphthyridine 3 carboxylic acid and method for its preparation us patent 4859776 august 22 1989. Official Gazette of the United States Patent and Trademark Office Patents 1105(4): 2630

Carr, R.D.; Dainty, I.A.; Hogg, S.; Marriott, D.B.; Nicol, A.K.; O'connor S.E.; Leff, P. 1989: S 8307 is a suitable antagonist of angiotensin ii for endocrinological investigations. Journal of Endocrinology 123(Suppl): 155

Terret, C.; Le Cesne, A.; Lagarde, N.; Di Palma, M.; Goncalves, E.; N'dom, P.; Yataghene, Y.; Funck Brentano, C.; N'guyen, J.P.; Marino, J.P.; Besse, B.; Armand, J.P.; Le Chevalier, T.; Belpomme, D.; Misset, J.L.; D'agay, L.; Berger, E.; Sarkany, M.; Giroux, B. 1996: S 9788 a multidrug resistance reversing agent French phase I studies with a 6 hour continuous infusion schedule in combination with chemotherapy in patients with refractory cancer. Proceedings of the American Association for Cancer Research Annual Meeting 37: 165-166

Soudon, J.; Berlion, M.; Bizzari, J.P.; Calvo, F. 1992: S 9788 completely reversed multidrug resistance mdr in a human leukemic t cell line without increasing vinblastine and doxorubicin toxicity on cfu gm and bfu e. Proceedings of the American Association for Cancer Research Annual Meeting 33: 484

Nikonov, A.A. 1973: S A Zakharovs observations on A A Nikonovs article, Differential analysis of Quaternary tectonics of the Afghan-Tadzhik Depression Geotektonika, No 1, 1970. Geotectonics 5: 314-315

Anonymous 1981: S Africa; the rate of change. Mining Journal (London) 297(7631): 381-383

Okuse, K.; Sivilotti, L.; Moss, S.; Akopian, A.N.; Wood, J.N. 1996: S F confers tetrodotoxin sensitivity on the sensory neuron specific sodium channel SNS. Society for Neuroscience Abstracts 22(1-3): 62

Anonymous 1995: S I Dovzhansky. Vestnik Dermatologii I Venerologii 1995(6): 63

Levin, B. 1934: S Linfluence de loxygene sur l-action antitoxique de la cholesterine sur les saponines. Compt Rend Acad Science Paris 198(20): 1812-1814

Kupriyanov, V.V.S.P. 1956: S P Krasheninnikov and his pupil K I Shchepin New material towards a biography of S P Krasheninnikov. Bot Zhur 41(4): 592-596

Grigorev, D.P. 1948: S S Smirnov kak mineralog. Zapiski Vsesoyuznogo Mineralogicheskogo Obshchestva 77(1): 9-14

Spencer, L.T. 1995: S Stillman Berry and the development of the Scripps Institution of Oceanography Library. American Zoologist 35(5): 55A

Bergey, G.K. 1994: S Weir Mitchell and his observations of psychogenic seizures. Neurology 44(4 Suppl 2): A148

Sarda, N.; Gharib, A.; Pacheco, H. 1989: S adenosyl l homocysteine adenosine and l homocysteine on sleep. Wauquier, A , C Dugovic And M Radulovacki (Ed ) Slow Wave Sleep: Physiological, Pathophysiological, And Functional Aspects; International Symposium on Current Trends in Slow Wave Sleep Research, Beerse, Belgium, June 25-27, 1987 Xvii+331p Raven Press: New York, New York, Usa Illus 257-272

Arnsmeier, S.L.; Mirkin, B.L.; Clark, S.H.; Paller, A.S. 1992: S adenosyl l homocysteine hydrolase pathway in keratinocytes and squamous cell carcinomas. Journal of Investigative Dermatology 98(4): 639

Andreoli, V. 1991: S adenosyl l methionine adomet as an antidepressant. Racagni, G , N Brunello And T Fukuda (Ed ) International Congress Series, No 968 Biological Psychiatry, Vols 1 And 2; Proceedings Of The 5th World Congress Of Biological Psychiatry, Florence, Italy, June 9-14, Xxviii+886p (Vol 1); Xxxi+949p (Vol 2) Elsevier Science Publishers B V : Amsterdam, Netherlands; (Dist in The Usa And Canada By Elsevier Science Publishing Co , Inc : New York, New York, Usa) Illus 630-633

Casini, A.; Leo, M.A.; Kim, C.; Lieber, C.S. 1989: S adenosyl l methionine adomet attenuates ethanol induced adomet depletion and associated liver injury in the baboon. Hepatology 10(4): 701

Roberts, M.F.; Osoba, O.A.; Homeyer, B.C. 1989: S adenosyl l methionine methyltransferases in ailanthus altissima mill. Journal of Pharmacy and Pharmacology 41(Suppl): 71P

Zhong, P.; Mcwilliam, J.; Kellar, K.J. 1990: S adenosyl l methionine modulates receptor mediated cyclic amp production in rat brain. Society for Neuroscience Abstracts 16(2): 1302

Basista, M. 1991: S adenosyl l methionine prevents ethanol alteration of kupffer cell immune function. Gastroenterology 100(5 Part 2): 718

Larrauri, A.; Castell, J.V.; Garrido, G.; Berenguer, J.; Gomez Lechon, M.J. 1989: S adenosyl l methionine reverses ethynylestradiol induced impairment of taurocholate uptake in primary cultures of rat hepatocytes. Gastroenterology 96(5 Part 2): A619

Kask, A.M.; Marin, C.; Chase, T.N. 1989: S adenosyl l methionine reverses tolerance produced by chronic haloperidol treatment in rats. Society for Neuroscience Abstracts 15(1): 268

Sweiry, J.H.; Bottiglieri, T.; Braganza, J.M.; Mann, G.E. 1991: S adenosyl l methionine same and its role in experimental pancreatitis. Digestion 49(1): 57

Andreoli, V. 1991: S adenosyl l methionine same as an antidepressant. Quaderni Italiani di Psichiatria 10(3): 201-219

Bradley, J.; Flusser, D.; Brandt, K.; Katz, B.; Chambers, M. 1991: S adenosyl methionine same in the treatment of osteoarthritis oa of the knee. Arthritis and Rheumatism 34(9 Suppl): S86

Reynolds, E.H.; Godfrey, P.; Bottiglieri, T.; Toone, B.K.; Carney, M.W.P. 1989: S adenosylmethionine and alzheimers disease. Neurology 39(3 Suppl 1): 397

Dunne, B.; Davenprot, M.; Tredger, J.M. 1992: S adenosylmethionine and n acetylcysteine in the treatment of experimental ischaemic liver injury. Journal of Hepatology 16(Suppl 1): S46

Pascale, R.; Daino, L.; Satta, G.; Simile, M.; Seddaiu, M.A.; Puddu, M.; Feo, F. 1989: S adenosylmethionine content dna methylation and gene expression in persistent liver nodules induced by the solt farber protocol. Proceedings of the American Association for Cancer Research Annual Meeting 30: 186

Byers, T.J.; Hugo, E.R. 1990: S adenosylmethionine decarboxylase a possible role in the encystment of acanthamoeba castellanii. IOVS Investigative Ophthalmology and Visual Science 31(4): 420

Pall, H.S.; Surtees, R.; Sturman, S.G.; Powell, A.; Williams, A.C. 1992: S adenosylmethionine in cerebrospinal fluid in parkinsons disease pd. Neurology 42(4 Suppl 3): 283

Bottiglieri, T.; Godfrey, P.; Toone, B.; Carney, M.W.P.; Reynolds, E.H. 1990: S adenosylmethionine metabolism in depression and dementia. Journal of Neurology Neurosurgery and Psychiatry 53(2): 179

Bray, G.P.; Tredger, J.M.; Williams, R. 1990: S adenosylmethionine protects against acetaminophen hepatotoxicity in mice. Gastroenterology 98(5 Part 2): A571

Rafique, S.; Guardascione, M.; Burroughs, A.K.; Owen, J.S. 1990: S adenosylmethionine reduces cholesterol deposition in erythrocyte membranes of cirrhotic patients. Journal of Hepatology 11(Suppl 2): S51

Crowell, B.Jr; Spector, S.; Charlton, C. 1991: S adenosylmethionine sam induced hypokinesia blocked by l dopa but not d dopa relevance to parkinsons disease pd. Society for Neuroscience Abstracts 17(1-2): 703

Zhong, P.; Kellar, K.J. 1991: S adenosylmethionine sam modulation of beta adrenoceptor mediated cyclic amp production possible relationship to methylation of the carboxyl terminus of a small g protein. Society for Neuroscience Abstracts 17(1-2): 606

Fischer, G.; Sagesser, H.; Talos, C.; Reichen, J. 1992: S adenosylmethionine same does not restore microsomal function in rats with secondary biliary cirrhosis sbc but improves transsulphuration. Journal of Hepatology 16(Suppl 1): S71

Vendemiale G.; Altomare E.; Altavilla R.; Le Grazie C.; Di Padova C.; Albano O. 1989: S adenosylmethionine same improves acetaminophen metabolism in cirrhotic patients. Journal of Hepatology 9(Suppl 1): S240

Gentile S.; Persico M.; Russo F.S.; Le Grazie C.; Di Padova C.; Coltorti M. 1990: S adenosylmethionine same improves bilirubin handling in cirrhotic patients. European Journal of Clinical Investigation 20(2 Part 2): A8

Rafique, S.; Guardascione, M.; Burroughs, A.K.; Owen, J.S. 1991: S adenosylmethionine same in the treatment of benign recurrent intrahepatic cholestasis bric. European Journal of Clinical Investigation 21(2 Part 2): 30

Bonfirraro G.; Chieffi O.; Quinti R.; Tedesco R.; Le Grazie C. 1990: S adenosylmethionine same in the treatment of intrahepatic cholestasis of pregnancy icp. European Journal of Clinical Investigation 20(2 Part 2): A24

Persico M.; Gentile S.; Di Padova C.; Le Grazie C.; Coltorti M. 1990: S adenosylmethionine same induced improvement of hepatic handling of organic anions in cirrhosis. Gastroenterology 98(5 Part 2): A620

Ahn, K.S.; Henney, H.R. 1991: S adenosylmethionine synthetase gene of acanthamoeba. Abstracts of the General Meeting of the American Society for Microbiology 91: 184

Bacchi, C.J.; Yarlett, N.; Garofalo, J.; Ciminelli, M.; Goldberg, B. 1991: S adenosylmethionine synthetase in trypanosoma brucei. American Journal of Tropical Medicine and Hygiene 45(3 Suppl): 207

Pegg, A.E.; Erwin, B.G. 1989: S alkylated coenzyme a with effect on polyamine acetylase us patent 4826968 may 2 1989. Official Gazette of the United States Patent and Trademark Office Patents 1102(1): 500

Imperiali, B.; Fisher, S.L. 1991: S alpha amino 2 2 bipyridine 6 propanoic acid a versatile amino acid for de novo metalloprotein design. Journal of the American Chemical Society 113(22): 8527-8528

Gobert, J.; Geerts J P.; Dodson, G. 1989: S alpha ethyl 2 oxo 1 pyrrolidineacetamide compositions us patent 4837223 june 6 1989. Official Gazette of the United States Patent and Trademark Office Patents 1103(1): 487

Sam, E.; Verbeke, N. 1994: S and R apomorphine are free radical scavengers. European Journal of Pharmaceutical Sciences 2(1-2): 128

Craft, C.M.; Whitmore, D.H.; Gonzalez, R.; Thai, T.H. 1991: S antigen arrestin family expression and identification of multiple forms in rat and bovine tissues with sympathetic innervation. Society for Neuroscience Abstracts 17(1-2): 1184

Merryman, C.F.; Gregerson, D.; Sery, T.W.; Donoso, L.A. 1989: S antigen disassociation of t cell epitopes responsible for uveitopathogenicity adoptive transfer of disease and lymphocyte proliferation. IOVS Investigative Ophthalmology and Visual Science 30(3): 278

Merryman, C.F.; Smith, N.; Donoso, L.A.; Gregerson, D.S. 1990: S antigen identification of a new region consisting of two separate proliferative sites and two adjacent uveitogenic sites that transfer eau. IOVS Investigative Ophthalmology and Visual Science 31(4): 511

Mohay J.; Resende R.; Mirshahi M.; De Kozak Y.; Thillaye B.; Faure J P. 1991: S antigen in the developing normal and rcs retina a monoclonal antibody study. Documenta Ophthalmologica 77(2): 100

Sai, S.; Usukura, J.; Shinohara, T.; Wakabayashi, T.; Awaya, S. 1991: S antigen localization in the developing rds mouse retina. IOVS Investigative Ophthalmology and Visual Science 32(4): 1134

Kawashima, H.; Fujino, Y.; Mochizuki, M. 1989: S antigen specific suppressor cells induced by fk 506. IOVS Investigative Ophthalmology and Visual Science 30(3): 279

Dua, R.K.; Taylor, E.W.; Phillips, R.S. 1992: S aryl l cysteine sulfone a new class of mechanism based inhibitors of kynureninase. Abstracts of Papers American Chemical Society 203(1-3): MEDI119

Clifton, G.D.; Mccoy, R.A.; Clementi, W.A.; Smith, M.D.; Garvey, T.Q.; Schwartz, S.E. 1992: S atenolol s accounts for the negative chronotropic and inotropic responses of r s atenolol rs. Clinical Pharmacology and Therapeutics 51(2): 173

Nielsen, J.; Jorn, H.; Kolmos, J.; Espersen, F. 1997: S aureus bacteremia among patients on dialysis. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 168A

Battan, R.; Raviglione, M.C.; Wallace, J.; Cort, S.; Boyle, J.F.; Taranta, A. 1991: S. aureus nasal carriage among homosexual men with and without HIV infection. American Journal of Infection Control 19(2): 98-100

Simonetti, M.P.B.; Fernandes, L. 1997: S bupivacaine and RS bupivacaine A comparison of effects on the right and left atria of the rat. Regional Anesthesia 22(2 Suppl): 58

Hampton, A.; Eddine, J.J. 1990: S c5 homocysteine adenosine adducts as potential s adenosylhomocysteine hydrolase inhibitors. Abstracts of Papers American Chemical Society 199(1-2): MEDI 28

Staffeldt, B. 1992: S carboxymethylcysteine disposition in humans metabolite recovery in urine after oral and intravenous application. Naunyn-Schmiedeberg's Archives of Pharmacology 345(Suppl 1): R25

Moulder, K.; Barton, A.; Weston, B. 1991: S cd23 cleavage of cd23 is essential for cd23 mediated homotypic adhesion. Journal of Cellular Biochemistry Suppl (15 Part F): 76

Becam, A.M.; Nasr, F.; Jia, Y.; Slonimski, P.P.; Herbert, C.J. 1994: S cerevisiae An economical genome?. Cell Biology International 18(5): 361

Weiss, E.; Herbert, C.; Mcdonald, K.; Drubin, D. 1998: S cerevisiae CBK1/ynl161, an orb6/MDPK related protein kinase, is required for cell separation following cytokinesis. Molecular Biology of the Cell 9(Suppl ): 232A

Vlckova, V.; Slaninova, M.; Henriques, J.A.P.; Brozmanova, J. 1996: S cerevisiae PSO4 gene as a candidate for the E coli recA-like activity in induced mutagenesis. Mutation Research 360(3): 223-224

Swartzman, E.; Viswanathan, M.N.; Emerick, A.E.; Thorner, J. 1994: S cerevisiae SSH2 gene product, homologous to human ALDP and PMP 70, is required for peroxisome function in vivo. Molecular Biology of the Cell 5(Suppl ): 479A

Drees, B.; Bretscher, A.; Brown, C.; Barrell, B. 1993: S cerevisiae contains a second tropomyosin, encoded by TPM2, which is functionally distinct from the TPMI1 gene product. Molecular Biology of the Cell 4(Suppl ): 3A

Ghoneum, M.; Matsuura, M.; Braga, M.; Gollapudi, S. 2008: S. cerevisiae induces apoptosis in human metastatic breast cancer cells by altering intracellular Ca2+ and the ratio of Bax and Bcl-2. International Journal of Oncology 33(3): 533-539

Kearns, B.G.; Bankaitis, V.A. 1994: S cerevisiae sac1 mutants exhibit elevated levels of highly modified inositol sphingolipids and an inositol auxotrophy that is corrected by disruption of the CDP-choline pathway for phospholipid biosynthesis. Molecular Biology of the Cell 5(Suppl ): 440A

Herr, S.S.; Tiv, N.; Sterling, P.; Schein, S.J. 1996: S cones in macaque fovea are invaginated by one type of on bipolar cell, but L and M cones are invaginated by midget and diffuse bipolar cells. IOVS Investigative Ophthalmology and Visual Science 37(3): S1059

Chavdarian, C.G. 1989: S cycloalkylmethyltrithiophosphonate insecticides us patent 4837209 june 6 1989. Official Gazette of the United States Patent and Trademark Office Patents 1103(1): 482

Klein, G.; Neff, H.; Kullich, W.; Phleps, W.; Kollenz, C.J. 1992: S dextro versus racemic ibuprofen. Lancet 339(8794): 681

Lin, B.; Dietrich, W.D.; Busto, R.; Ginsberg, M.D. 1990: S emopamil protects against global ischemic injury in rats. Stroke 21(1): 177

Block, F.; Jaspers, R.M.A.; Sontag K H. 1990: S emopamil reduces ischemic brain damage in rats subjected to 4 vessel occlusion histological and behavioral evidences. European Journal of Pharmacology 183(4): 1469

Peskar, B.M.; Beck, W.S.; Geisslinger, G.; Menzel Soglowek, S.; Brune, K. 1991: S enantiomers and r enantiomers of flurbiprofen differ in gastrointestinal toxicity inhibition of prostaglandin formation and anti inflammatory effects but not analgesic activity. Gastroenterology 100(5 Part 2): A138

Crisi, G.M.; Santambrogio, L.; Hochwald, G.M.; Smith, S.R.; Carlino, J.A.; Thorbecke, G.J. 1995: S enterotoxin B and tumor necrosis factor-alpha induced relapses of experimental allergic encephalomyelitis. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY The 9th International Congress of Immunology : 390

Ponto, J.A. 1989: S factors for self dose to large tumors from selected therapeutic radionuclides. Journal of Nuclear Medicine 30(5 Suppl): 883

Prasadarao, N.V.; Wass, C.A.; Kim, K.S. 1993: S fimbriae binding proteins of brain microvascular endothelial cells. FASEB Journal 7(3-4): A827

Ghany, M.G.; Ayola, B.; Villamil, F.G.; Gish, R.; Rojter, S.; Vierling, J.M.; Lok, A.S.F. 1995: S gene escape mutants as a cause of HBV reinfection in patients who received HBIG post-OLT. Hepatology 22(4 Part 2): 150A

Ghany, M.G.; Ayola, B.; Villamil, F.G.; Gish, R.; Rojter, S.; Vierling, J.M.; Lok, A.S.F. 1996: S gene escape mutants as a cause of HBV reinfection in patients who received HBIG post-liver transplant. Journal of Investigative Medicine 44(1): 32A

Kavarana, M.; Creighton, D.; Eiseman, J. 1996: S glutathione diethyl diesters Membrane transport properties, in vitro antitumor activities, and serum stabilities. Proceedings of the American Association for Cancer Research Annual Meeting 37: 296

Hoeckerstedt, K.; Isoniemi, H.; Risteli, L.; Risteli, J. 1992: S ictp in pbc predicts severe bone disease after transplantation. Journal of Hepatology 16(Suppl 1): S47

Armstrong, E.; Ziola, B.; Habbick, B.; Komiyama, K. 1991: S iga and saliva mediated aggregation of pseudomonas aeruginosa in patients with cystic fibrosis. Journal of Dental Research 70(Special Issue): 498

Wisnewski, A.V.; Kresina, T.F. 1994: S japonicum egg antigen specific human T cell lines derived in vitro from the peripheral blood lymphocytes of a naive donor. FASEB Journal 8(4-5): A801

Walker Caprioglio, H.M.; Mcguire, P.G.; Little, S.A.; Santistevan, C.; Avritt, S.A.; Hunter, D.D.; Mcguffee, L.J. 1992: S laminin in rat vascular tissue. FASEB Journal 6(4): A1042

Weis, J.; Hunter, D.D.; Merlie, J.P.; Sanes, J.R. 1989: S laminin inhibits neurite extension promoted by laminin. Society for Neuroscience Abstracts 15(1): 164

Cho, W.T.; Kim, W.S.; Kim, M.K.; Park, J.K.; Kim, H.R.; Rhee, S.K.; Domracheva, A.G.; Panichkina, T.B.; Saburoba, L.A.; Nobikoba, L.M.; Bartochevichi, Y.E. 1995: S lavendofoliae DKRS cell culture producing anti-tumor aclacinomycins A, B, Y and aglycones. Official Gazette of the United States Patent and Trademark Office Patents 1180(3): 1759

Smarda, J. 1991: S layer of chroococcal cell walls. Archiv fur Hydrobiologie, Supplementband 92: 41-51

Bertilsson, L. 1989: S mephenytoin hydroxylation polymorphism association with the metabolism of other drugs and ethnic differences. Revista de Farmacologia Clinica y Experimental 6(3): 187-188

Young, R.; Glennon, R.A. 1995: S methcathinone as a discriminative stimulus Effects of other CNS stimulants. Society for Neuroscience Abstracts 21(1-3): 2105

Yasui, S.; Furukawa, T.; Yamada, M.; Saito, T. 1992: S n dependent modulation of centre surround opponent receptive fields similarities in real and artificial neural networks. Journal of Physiology (Cambridge) 446: 376P

Ulbrich, R.; Famulok, M.; Bosold, F.; Boche, G. 1990: S n2 at nitrogen the reaction of n 4 cyanophenyl o diphenylphosphinoylhydroxylamine with n methylaniline a model for the reactions of ultimate carcinogens of aromatic amines with bionucleophiles. Tetrahedron Letters 31(12): 1689-1692

Kearney, J.F.Jr; Simon, D.I.; Stamler, J.S.; Jaraki, O.; Vita, J.A.; Loscalzo, J. 1991: S nitroso bovine serum albumin an nitric oxide adduct with unique hemodynamic properties. Circulation 84(4): II672

Shultz, P.; Ruble, D.; Raij, L. 1990: S nitroso n acetylpenicillamine snap inhibits mitogen induced mesangial cell proliferation. Kidney International 37(1): 203

Cooke, J.P.; Andon, N.; Delduca, D.; Dzau, V.; Loscalzo, J. 1989: S nitrosocaptopril a novel vasodilator resistant to nitrate tolerance. Circulation 80(4 Suppl 2): II559

Jansen, A.; Drazen, J.M.; Loscalzo, J.; Brown, R.; Sugarbaker, D.A.; Stamler, J.S. 1991: S nitrosothiols a new class of bronchodilators. American Review of Respiratory Disease 143(4 Part 2): A630

Helia, O.; Paulikova, I. 1992: S oxygenation of oxyprothepine contribution of the flavin containing monooxygenase. Die Pharmazie 47(2): 151-152

Hooffstetter, J.; Smith, A.; Bieri, M. 1993: S phase analysis in radical prostatectomy patients. Clinical Research 41(1): 31A

Witzig, T.E.; Gonchoroff, N.J.; Stenson, M.J.; Katzmann, J.A.; Grant, C.S.; Wold, L.E.; Ingle, J.N. 1990: S phase analysis using a bromodeoxyuridine labeling index li method comparison with percent s phase determined by flow cytometry fc. Journal of Cellular Biochemistry Suppl (14 Part B): 344

Kolquist, K.A.; Cibull, M.L.; Jennings, C.D.; Davey, D.D. 1992: S phase as a prognostic indicator in large cell lymphoma. Laboratory Investigation 66(1): 80A

Dixon, P.S.; Shenberger, J.S. 1998: S phase blockade and increased p21 levels in O2-exposed airway smooth muscle cells. Proceedings of the American Association for Cancer Research Annual Meeting 39: 243-244

Ryan, A.J.; Strutt, H.L.; Evans, A.; Squires, S.; Johnson, R.T. 1992: S phase cytotoxicity of camptothecin, a specific inhibitor of topoisomerase I, is associated with the induction of double-strand breaks in replicating DNA, and results in chromatid-type aberrations at mitosis. Mutagenesis 7(5): 392

Larner, J.M.; Lee, H.; Hamlin, J.L. 1997: S phase damage sensing checkpoints in mammalian cells. Cancer Surveys 29: 25-45

Hunt, A.N.; Burdge, G.C.; Wright, S.M.; Postle, A.D. 1998: S phase depletion of nuclear CTP:choline phosphate cytidylyltransferase. Biochemical Society Transactions 26(3): S222

Wingren, S.; Stal, O.; Sun, X.F.; Nordenskjold, B. 1992: S phase determination of immunoselected cytokeratin containing breast cancer cells improves the prediction of recurrence. Analytical Cellular Pathology 4(3): 251

Tommasi S.; Paradiso A.; Giannella C.; Barletta A.; Mangia A.; De Lena M. 1991: S phase fraction and dna ploidy related to her 2 neu alterations. Proceedings of the American Association for Cancer Research Annual Meeting 32: 292

Frankforter, S.; Abels, K.; Grant, D.; Linder Stephenson, L.; Bewtra, C.; Marcus, J. 1992: S phase fraction as a discriminator of hydatidiform moles and non molar hydropic products of conception. Laboratory Investigation 66(1): 64A

Schmidt, R.A.; Rabinovitch, P.S.; Conradi, E.U.I.; Bavisotto, L. 1996: S phase fraction as a strong predictor of chemosensitivity in soft tissue sarcomas. Modern Pathology 9(1): 13A

Laskey, R.A.; Fairman, M.P.; Blow, J.J. 1989: S phase of the cell cycle. Science 246(4930): 609-614

Orr Weaver, T.; Shamanski, F.; Smith, A.; Lahue, E.; Lafreniere, D.; Carminati, J. 1992: S phase regulation in drosophila embryogenesis. Biophysical Journal 61(2 Part 2): A538

Kurian, P.; Sital, N.; Zhang C X.; Milo, G. 1990: S phase susceptibility of human skin epithelial cells to transformation by transfection with psvc myc 1. Proceedings of the American Association for Cancer Research Annual Meeting 31: 108

Hashimoto, M.; Taniguchi, M.; Yoshino, S.; Arai, S.; Sato, K. 2008: S Phase-preferential Cre-recombination in mammalian cells revealed by HIV-TAT-PTD-mediated protein transduction. Journal of Biochemistry 143(1): 87-95

Chang, F.; Nurse, P.; Drubin, D. 1996: S pombe cdc12 is required for contractile actin ring assembly and cytokinesis. Molecular Biology of the Cell 7(Suppl ): 228A

Tavassoli, M.; Watts, F.Z. 1997: S pombe rad32 protein A phosphoprotein required for mating type switching. Mutation Research 379(1 Suppl 1): S59

Ohi, H.; Sakamoto, K.; Hatano, M. 1990: S protein (vitronectin) in hemodialysis patients. Nephron 54(2): 190-191

Crozet, M.P.; Vanelle, P.; Jentzer, O.; Maldonado, J. 1990: S r n 1 reactions in a heterocyclic series v comparison of the reactivities of dimethyl 1 2 chloro 1 ethyl 4 nitro 5 imidazole and of the ortho nitrobenzyl system. Tetrahedron Letters 31(9): 1269-1270

Vanelle, P.; Maldonado, J.; Madadi, N.; Gueiffier, A.; Teulade J C.; Chapat J P.; Crozet, M.P. 1990: S r n1 reactions in imidazo 1 2 a pyridine series. Tetrahedron Letters 31(21): 3013-3016

Rosenthall, L.; Brooks, C.E. 1992: S rom hip prosthesis quantitative measurements of normal periprosthetic uptake of mdp as a function of time in asymptomatic patients. Journal of Nuclear Medicine 33(5 Suppl): 950

Gough, S.T.D. 1989: S s di tert butylethylphosphonodithioate as pesticides us patent 4810698 march 7 1989. Official Gazette of the United States Patent and Trademark Office Patents 1100(1): 441

Lindner, W.; Uray, G.; Steiner, U. 1991: S s diphenylethylethanediamine derivatives as chiral selectors ii gasparrini type bound chiral stationary phase with high enantioselectivity for naphthylamides. Journal of Chromatography 553(1-2): 373-382

Rokutan, K.; Nakamura, K.; Kutsumi, H.; Niki, S.; Johnston, R.B.Jr; Aoike, A. 1991: S thiolation of actin in cultured gastric mucus secreting cells under oxidative stress. Journal of Cell Biology 115(3 Part 2): 161A

Farina, A.R.; Tiberio, A.; Tacconelli, A.; Gulino, A.; Mackay, A.R. 1997: S to N phenotypic conversion of human neuroblastoma cell line SK-N-SH increases invasive capacity by up-regulating the expression of t-PA and MMP-9 and down-regulating that of TIMPs. Proceedings of the American Association for Cancer Research Annual Meeting 38: 410

Cullen, T.G.; Martinez, A.J.; Willut, J.M.; Disanzo, C.P.; Vukich, J.J. 1990: S trifluorobutene n cyanoimidodithiocarbonic acid esters as nematicides. Abstracts of Papers American Chemical Society 199(1-2): AGRO 11

Cullen, T.G.; Martinez, A.J.; Willut, J.M.; Disanzo, C.P.; Vukich, J.J. 1990: S trifluorobutenyl n substituted dithiocarbamates as nematicides. Abstracts of Papers American Chemical Society 199(1-2): AGRO 10

Stein, L.B.; Bank, S.; Greenberg, R.; Dabezies, M.A.; Jagathambal, K.; Rai, K. 1991: S type hyperamylasemia a poor prognostic indicator in patients with hematologic malignancies. Gastroenterology 100(5 Part 2): A300

Ali, W.; Buch, N.A.; Hassan, M. 1996: S. typhi infection in congenital nephrotic syndrome. Indian Journal of Pediatrics 63(3): 409-412

Kops, S.K.; West, A.B. 1995: S typhi penetrates epithelial cell monolayers by a novel mechanism. Gastroenterology 108(4 Suppl): A852

Zhou, D.; Galan, J.E. 1998: S typhimurium encodes an actin-binding protein that modulates the bundling activity of plastin to promote bacterial entry into host cells. Molecular Biology of the Cell 9(Suppl ): 386A

Mastroeni, P.; Harrison, J.A.; Robinson, J.H.; Hormaeche, C.E. 1997: S typhimurium infection in mice treated with anti-IL12 antibodies. Immunology 92(Suppl 1): 77

Tenbrink, R.E.; Bergh, C.L.; Duncan, J.N.; Harris, D.W.; Huff, R.M.; Lahti, R.A.; Lutzke, B.S.; Martin, I.J.; Sih, J.C.; Smith, M.W. 1997: S- -4- ethylpiperazin-1-ylbenzenesulfonamide, a high affinity, selective antagonist for the human dopamine D-4 receptor. Abstracts of Papers American Chemical Society 213(1-3): MEDI 163

Verstegen Haaksma, Anja A.; Swarts, Henk J.; Jansen, Ben J.M.; De Groot, Aede 1994: S- -Carvone as starting material in synthesis Part 4 Conjugate addition of cyanide and Grignard nucleophiles followed by annulation to functionalized decalones. Tetrahedron 50(33): 10073-10082

Morrow, B.A.; Lee, E.J.K.; Elsworth, J.D.; Nye, H.E.; Roth, R.H. 1995: S- -HA-966, a gamma-hydroxybutyrate-like agonist, blocks behavioral and mesoaccumbal, in addition to mesocortical, dopaminergic stress activation. Society for Neuroscience Abstracts 21(1-3): 852

Adams, H.A. 1997: S- -ketamine Cardiovascular interactions during total intravenous anaesthesia and analgosedation. Anaesthesist 46(12): 1081-1087

Marhofer, P.; Krenn, C.G.; Hochtl, A.; Wallner, T.; Semsroth, M. 1998: S- ketamine for caudal blockade in pediatric anesthesia. Anesthesiology 89(3A): A1247

Ge, J.; Towers, P.; Patel, A.C.; Barnes, N.M. 1994: S- zacopride labels a 5-HT-sensitive non-5-HT-3 recognition site in rat ileum. British Journal of Pharmacology 114(Proceedings Suppl ): 376P

Schmitz, F.; Plenevaux, A.; Del Fiore, G.; Lemaire, C.; Aerts, J.; Luxen, A. 1995: S-, N- and O- methylations of a Nor precursor adsorbed on Al-2O-3/KF. Journal of Labelled Compounds and Radiopharmaceuticals 37: 749-751

Schmitz, F.; Plenevaux, A.; Del Fiore, G.; Lemaire, C.; Aerts, J.; Luxen, A. 1995: S-, N- and O- methylations of a nor precursor adsorbed on AI-2Q-3/KF. Journal of Labelled Compounds and Radiopharmaceuticals 37: 106-108

Dominguez, C.; Carini, D.; Knabb, R.M.; Alexander, R.S.; Kettner, C.A.; Weber, P.C. 1996: S-1 heterocyclic thrombin inhibitors. Abstracts of Papers American Chemical Society 211(1-2): MEDI 129

Furuse, J.; Okusaka, T.; Boku, N.; Ohkawa, S.; Sawaki, A.; Masumoto, T.; Funakoshi, A. 2008: S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase Ii study. Cancer ChemoTherapy and Pharmacology 62(5): 849-855

Hakernarson, H.; Benard, F.; Shiue, C.Y.; Khattri, P.; Shiue, G.G.; Karp, J.S.; Grunstein, M.M.; Alavi, A.; Berridge, M.S. 1997: S-1- fluorocarazolol A ligand for studying the modulation of beta-adrenergic receptors in asthmatic lung. Journal of Labelled Compounds and Radiopharmaceuticals 40: 668-669

Hansson, L.O.; Djuren, E.; Von Schoultz, E.; Dijlai Merzog, R.; Nilsson, B.; Hansson, J. 1997: S-100 B in malignant melanoma. Tumor Biology 18(Suppl 2): 74

Markovic Lipkovski, J.; Todorovic, V.; Radotic Smiljanic, K.; Knezevic Usaj, S.; Jovanovic, O.; Basta Jovanovic, G. 1995: S-100 Positive renal dendritic cells. Pathology Research and Practice 191(7-8): 723

Harris, D.; Gao, F.; Wilson, J.; Sapsed Byrne, S.; Smith, P.; Taylor, K. 1996: S-100 concentrations during hypothermic and normothermic cardiopulmonary bypass. British Journal of Anaesthesia 77(5): 695P-696P

Bianchi, R.; Giambanco, I.; Donato, R. 1992: S-100 protein binds to and inhibits the polymerization of the glial fibrillary acidic protein in a calcium-dependent way. Molecular Biology of the Cell 3(Suppl ): 340A

Bianchi, R.; Pula, G.; Ceccarelli, P.; Giambanco, I.; Donato, R. 1992: S-100 protein binds to annexin Ii and p11, the heavy and light chains of calpactin i. Biochimica et Biophysica Acta 1160(1): 67-75

Bonfrer, J.M.G.; Korse, C.M.; Israels, S.P. 1996: S-100 protein concentrations is increased in patients with malignant melanoma. Tumor Biology 17(Suppl 1): 62

Hoda, S.A.; Reed, R.J. 1993: S-100 protein immunoreactivity differentiates follicular from papillary neoplasms of thyroid. Laboratory Investigation 68(1): 38A

Kraehn, G.; Kaskel, P.; Nolte, A.; Peter, R. 1997: S-100 protein in peripheral blood A tumor marker for malignant melanoma. Melanoma Research 7(Suppl 1): S94

Krahn, G.; Nolte, A.; Kaskel, P.; Peter, R.U.e 1997: S-100 protein in the peripheral blood of patients with primary malignant melanoma metastases. Tumor Biology 18(Suppl 1): 50

Skelton, H.G.; Smith, K.J. 1996: S-100 protein positive CD30 lymphoma Report of a case. Journal of Cutaneous Pathology 23(1): 93

Kumar, P.; Dhital, K.; Hossein-Nia, M.; Patel, S.; Holt, D.; Treasure, T. 1997: S-100 protein release in a range of cardiothoracic surgical procedures. Journal of Thoracic and Cardiovascular Surgery 113(5): 953-954

Pedrocchi, M.; Schaefer, B.W.; Heizmann, C.W. 1993: S-100 proteins are differentially expressed in tumour progression. Experientia 49(ABSTR ): A28

Rothoerl, R.D.; Woertgen, C.; Holzschuh, M.; Metz, C.; Brawanski, A. 1998: S-100 serum levels after minor and major head injury. Journal of Trauma 45(4): 765-767

Djureen Martenson, H.; Hansson, L.O.; Nilsson, B.; Hansson, J.; Von Schoultz, E.; Ringborg, U. 1997: S-100-beta protein in serum is an independent prognostic factor in malignant melanoma in all clinical stages. Melanoma Research 7(Suppl 1): S55

Sorci, G.; Bianchi, R.; Giambanco, I.; Rambotti, M.G.; Donato, R. 1996: S-100B colocalization with vimentin intermediate filaments in replicating rat L6 myoblasts. Molecular Biology of the Cell 7(Suppl ): 529A

Bonfrer, J.M.G.; De Feij De Graaf, H.M.; Korse, C.M.; Rankin, E. 1997: S-100B is a suitable marker for malignant melanoma. Tumor Biology 18(Suppl 2): 74

Djureen Martenson, E.; Hansson, L.O.; Nilsson, B.; Hansson, J.; Von Schoultz, E.; Ringborg, U. 1998: S-100B protein in serum is an independent prognostic factor in malignant melanoma in clinical stage II and III. Tumor Biology 19(Suppl 2): 29

Mealy, N.; Cataner, J. 1996: S-1090 Cephalosporin. Drugs of the Future 21(3): 254-257

Arita, H.; Kurosawa, A.; Oguma, T.; Kitamura, T.; Ebihara, A.; Narisada, M. 1992: S-1452 A novel TXA-2 receptor antagonist. Cardiovascular Drug Reviews 10(3): 280-295

Prous, J.; Mealy, N.; Castaner, J. 1994: S-1452 Platelet antiaggregatory thromboxane A-2 antagonist antiasthmatic. Drugs of the Future 19: 1011-1017

Amer, M.S. 1998: S-2- ethyl cinnamanlide. Official Gazette of the United States Patent and Trademark Office Patents 1212(2): 1842

Van Reeth, O.; Olivares, Y.; Zhang, F.W.; Turek, F.W.; Defrance, R.; Mocaer, E. 1994: S-20098, A melatonin-agonist, phase shifts the circadian clock of mice and Syrian hamsters according to a phase-response-curve. Society for Neuroscience Abstracts 20(1-2): 1440

Mocaer, E.; Tobler, I.; Danhof, M.; Sugden, D.; Porsolt, R.D.; Defrance, R.; Borbely, A.A. 1994: S-20098, a potent melatonin agonist is devoid of sleep-inducing effects at chronobiotic doses. Journal of Sleep Research 3(Suppl 1): 168

Flavin, H.J.; Daw, N.W. 1996: S-3,5-Dihydroxyphenylglycine potentiates the NMDA response of cortical neurons. Society for Neuroscience Abstracts 22(1-3): 66

Nehls, M.; Boehm, T. 1993: S-300 gel matrix irreversibly binds single-stranded nucleic acids. Trends in Genetics: Tig 9(10): 336-337

Kasina, S.; Gustavson, L.M. 1997: S-3N chelating compounds for the radiolabeling of ligands, anti-ligands or other proteins. Official Gazette of the United States Patent and Trademark Office Patents 1204(1): 505-506

Hearst, J.E.; Reames, A.; Grass, J.; Talib, S. 1998: S-59/UVA treated human T-cells with precisely controlled genomic addition frequencies retain immunological functions and yet are inhibited in proliferation. Blood 92(10 Suppl 1 Part 1-2): 292B

Mace, S.E.; Levy, M.N. 1997: S-A nodal pacemaker cell response to phasic vagal stimulation in puppies and adult dogs. Pediatrics 100(3 Part 2): 440

Casara, P.; Danzin, C. 1995: S-Adenosyl methionine decarboxylase inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1174(3): 1911

Srivastava, P.C.; Hasan, A. 1993: S-Adenosyl-L-homocysteine hydrolase as a potential target for diagnosis with radiohalogenated nucleosides. Journal of Labelled Compounds and Radiopharmaceuticals 32: 219-221

Kampfer, A.J.; Balog, E.M. 2008: S-Adenosyl-l-methionine activates the cardiac ryanodine receptor. Biochemical and Biophysical Research Communications 371(4): 606-609

Tambini, R.; Fracassetti, O.; Minola, E.; Gavazzeni, G. 1997: S-Adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy Preliminary results of a meta-analysis study. Journal of Hepatology 26(Suppl 1): 168

Travagli, R.A.; Gillis, R.A.; Kellar, K.J. 1993: S-Adenosyl-methionine decreases firing rate of dorsal motor nucleus of the vagus neurones in vitro in part by antagonizing I-H+. Society for Neuroscience Abstracts 19(1-3): 716

Beluzić, R.; Cuk, M.; Pavkov, T.; Barić, I.; Vugrek, O. 2008: S-Adenosylhomocysteine hydrolase (AdoHcyase) deficiency: enzymatic capabilities of human AdoHcyase are highly effected by changes to codon 89 and its surrounding residues. Biochemical and Biophysical Research Communications 368(1): 30-36

Cutrin, C.; Menino, M.; Pazo, J.A.; Perez Becerra, E.; Sande, L.; Barrio, E. 1992: S-Adenosylmethionine and steatosis in an experimental model of toxic liver injury in rats treated with carbon tetrachloride and ethanol. Medical Science Research 20(24): 943-944

Morrison, L.D.; Kish, S.J. 1992: S-Adenosylmethionine decarboxylase in human brain. Society for Neuroscience Abstracts 18(1-2): 1488

Chawla, R.; Hill, D.; Watson, B.; Eastin, C.; Perera, C.; St Clair, D.; Mcclain, C.J. 1995: S-Adenosylmethionine deficiency predisposes to TNF hepatotoxicity. Gastroenterology 108(4 Suppl): A1047

Imonitie, V.; Baker, D.; Schumacher, H.R.lph, J. 1992: S-Adenosylmethionine does not have anti-inflammatory effect on crystal-induced inflammation in the rat subcutaneous air pouch. Arthritis and Rheumatism 35(9 Suppl): S225

Pajares, M.A.; Duran, C.; Corrales, F.; Mato, J.M. 1993: S-Adenosylmethionine synthesis and its regulation. Amino Acids 5(3): 428

Segoviano-Murillo, S.; Sánchez-González, D.J.; Martínez-Martínez, C.M.ía.; Cruz, C.; Maldonado, P.D.; Pedraza-Chaverrí, J.é 2008: S-allylcysteine ameliorates ischemia and reperfusion induced renal damage. PhytoTherapy Research: Ptr 22(6): 836-840

Ren, J.; Shichi, H. 1994: S-Antigen-specific suppressor cell induction in orchidic tolerance Preventions of EAU. IOVS Investigative Ophthalmology and Visual Science 35(4): 1863

Benboubker, L.; Linassier, C.; Ollivier, I.; Delain, M.; Valat, C.; Fetissof, F.; Lamagnere, J.P.; Colombat, P. 1996: S-CA125 and LDH levels as a new prognostic index in patients with non Hodgkins lymphomas. Blood 88(10 Suppl 1 Part 1-2): 224A

Farkkila, M.A.; Karvonen, A.L.; Pikkarainen, P.; Nurmi, H.; Nuutinen, H.; Miettinen, T.A. 1996: S-CA19-9 and S-CEA in primary sclerosing cholangitis. Gastroenterology 110(4 Suppl): A1188

Stein, C.; Rabbani, L. 1998: S-DC28 as an antirestenosis agent after balloon injury. Official Gazette of the United States Patent and Trademark Office Patents 1217(5): 4195

Casadei, M.; Persichini, T.; Polticelli, F.; Musci, G.; Colasanti, M. 2008: S-glutathionylation of metallothioneins by nitrosative/oxidative stress. Experimental Gerontology 43(5): 415-422

Hiddemann, W.; Unterhalt, M.; Kemper, M.; Schleyer, E.; Schoenrock Nabulsi, P.; Uharek, L.; Fromm, M.; Braumann, D.; Planker, M.; Kubicka, U.; Karow, J.; Lange, S.; Tirier, C.; Woermann, B.; Sauerland, C.; Heinecke, A.; Buechner, T. 1994: S-HAM salvage therapy in relapsed and refractory AML followed by interleukin 2 postremission therapy. Annals of Hematology 68(2): A9

Rubin, D.; Claas, S.; Pfeuffer, M.; Nothnagel, M.; Foelsch, U.R.; Schrezenmeir, J. 2008: S-ICAM-1 and s-VCAM-1 in healthy men are strongly associated with traits of the metabolic syndrome, becoming evident in the postprandial response to a lipid-rich meal. Lipids in Health and Disease 7: 32

Mitra, B.; Gerlt, J.A.; Babbitt, P.C.; Kenyon, G.L.; Joseph, D.; Petsko, G.A. 1994: S-Mandelate dehydrogenase from Pseudomonas putida Construction of a soluble chimeric mutant of a membrane-bound enzyme. Yagi, K Flavins and flavoproteins 1993 621-624

Bell, M.G.; Gernert, D.L.; Grese, T.A.; Belvo, M.D.; Borromeo, P.S.; Kelley, S.A.; Kennedy, J.H.; Kolis, S.P.; Lander, P.A.; Richey, R.; Sharp, V.Scott.; Stephenson, G.A.; Williams, J.D.; Yu, H.; Zimmerman, K.M.; Steinberg, M.I.; Jadhav, P.K. 2007: (S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor. Journal of Medicinal Chemistry 50(26): 6443-6445

Fujii, N.; Nakai, K.; Habashita, H.; Yoshizawa, H.; Ibuka, T.; Garrido, F.; Mann, A.; Chounan, Y.; Yamamoto, Y. 1993: S-N2 selective alkylation of allylic chlorides and mesylates with RZnX reagents generated from Grignard reagents, zinc chloride, lithium chloride, and copper -salts. Tetrahedron Letters 34(26): 4227-4230

Wipf, P.; Fritch, P.C. 1994: S-N2-Reactions of peptide aziridines A cuprate-based approach to -alkene isosteres. Journal of Organic Chemistry 59(17): 4875-4886

Reuter, D.C.; Flippin, L.A.; Mcintosh, J.; Caroon, J.M.; Hammaker, J. 1994: S-NAr reactions of benzaldimines A concise synthesis of substituted phenanthridines. Tetrahedron Letters 35(28): 4899-4902

Beugelmans, R.; Singh, G.P.; Bois Choussy, M.; Chastanet, J.; Zhu, J. 1994: S-NAr-based macrocyclization An application to the synthesis of vancomycin family models. Journal of Organic Chemistry 59(19): 5535-5542

Craven, P.A.; Studer, R.K.; De Rubertis, F.R. 1995: S-Nitroso-N-acetylpenicillamine suppresses increases in protein kinase C , transforming growth factor beta and collagen synthesis induced by high glucose in mesangial cells. Journal of the American Society of Nephrology 6(3): 1040

Stamler, J.S.; Jaraki, O.; Oborne, J.; Simon, D.; Keaney, J.; Vita, J.; Loscalzo, J. 1992: S-Nitroso-albumin is the predominant bioactive form of nitric oxide in human plasma. Circulation 86(4 Suppl 1): I757

Langford, E.; Brown, A.; Debelder, A.; Thomas, M.; Smith, R.; Martin, J.; Wainwright, R.; Radomski, M. 1994: S-Nitrosoglutathione inhibits coronary angioplasty induced platelet activation. European Heart Journal 15(ABSTR Suppl ): 528

Langford, E.J.; De Belder, A.J.; Lees, C.; Brown, A.S.; Moncada, S.; Campbell, S.; Martin, J.F. 1996: S-Nitrosoglutathione reduces platelet activation and hypertension in severe pre-eclampsia. European Heart Journal 17(ABSTR Suppl ): 10

Chiueh, C.C.; Rauhala, P.; Lin, M.Y. 1997: S-Nitrosoglutathione/nitric oxide system A possible antioxidative cellular defense system in the brain. Japanese Journal of Pharmacology 75(Suppl 1): 8P

Aronstam, R.S.; Martin, D.C.; Dennison, R.L.; Cooley, H.G. 1995: S-nitrosylation of m2 muscarinic receptor thiols disrupts receptor-G-protein coupling. Annals of the new York Academy of Sciences 757: 215-217

Gupta, B.; Raghav, S.K.; Das, H.R. 2008: S-nitrosylation of mannose binding lectin regulates its functional activities and the formation of autoantibody in rheumatoid arthritis. Nitric Oxide: Biology and Chemistry 18(4): 266-273

D.S.mplicio, P.; Lusini, L.; Giannerini, F.; Giustarini, D.; Bellelli, A.; Boumis, G.; Amiconi, G.; Rossi, R. 1998: S-Nitrosylation of thiol groups in haemoglobins from various species. Moncada, S, Nistico, G, Bagetta, G, Higgs, E A Nitric oxide and the cell: Proliferation, differentiation and death 47-59

Banerjee, D.; Harris, P.; Taylor, M. 1994: S-Phase analysis in non-Hodgkins lymphoma Subset restricted analysis reveals marked heterogeneity within histological grades. Modern Pathology 7(1): 102A

Crozet, M.P.; Vanelle, P.; Jentzer, O.; Donini, S.; Maldonado, J. 1993: S-R-N1 reactions of anthraquinone alkylating agents. Tetrahedron 49(48): 11253-11262

Bigalli, G.; Palombo, C.; Pratali, L.; Marraccini, P.; L'abbate, A. 1994: S-T depression on effort is related to heart rate response to exercise in patients with essential hypertension and no coronary artery disease. American Journal of Hypertension 7(4 Part 2): 157A

Arnberg, H.; Aronsson, A.C.; Letchocha, H.; Nilsson, S. 1997: S-TPA-M levels in transitional cell carcinoma of the urinary bladder cancer. Tumor Biology 18(Suppl 1): 44

Chai, Y.C.; Thomas, J.A. 1993: S-Thiolation of protein sulfhydryls in hepatocytes Stimulation by neutrophils, t-butyl hydroperoxide, and menadione. FASEB Journal 7(3-4): A658

Natalini, B.; Sardella, R.; Macchiarulo, A.; Pellicciari, R. 2008: S-trityl-(R)-cysteine, a powerful chiral selector for the analytical and preparative ligand-exchange chromatography of amino acids. Journal of Separation Science 31(4): 696-704

Koning, G.; Van Der Zwet, P.M.J.; Schiemanck, L.; Reiber, J.H.C. 1995: S-VHS video tape unacceptable for quantitative coronary arteriography. European Heart Journal 16(ABSTR Suppl ): 252

Donnerstag, B.; Ohlenschlaeger, G.; Goebel, C.; Treusch, G.; Traeger, L. 1995: S-acetylglutathione as apoptosis-inducing agent in cancer therapy. International Journal of Oncology 7(Suppl ): 970

Schroeder, H.; Leventis, R.; Silvius, J.R. 1996: S-acylation of cysteinyl-containing lipopeptides by mammalian cells. Biophysical Journal 70(2 Part 2): A407

Galloway, S.E.; Wertz, G.W. 2008: S-adenosyl homocysteine-induced hyperpolyadenylation of vesicular stomatitis virus mRNA requires the methyltransferase activity of L protein. Journal of Virology 82(24): 12280-12290

Gibraltarskaya, E.; Eilert, U. 1993: S-adenosyl-L-methionine 1,3-dihydroxy-N-methylacridone 3-O-methyltransferase A new enzyme from Ruta graveolens. Planta Medica 59(7 Suppl): A647

Paul, B. 1996: S-adenosyl-L-methionine and its cyclopentenyl analog, S-neplanocyl A-L-methionine Structure features. Abstracts of Papers American Chemical Society 211(1-2): ORGN 214

Ortiz, P.; Moreno, J.; Puerta, J.L.; Mato, J.M. 1993: S-adenosyl-L-methionine and the liver. Italian Journal of Gastroenterology 25(3): 135-137

Nakano, H.; Yamaguchi, M.; Kaneshiro, Y.; Yoshida, K.; Kigawa, G.; Nagasaki, H.; Fujiwara, Y.; Matsumoto, F.; Kitamura, N.; Sasaki, J.; Kuzume, M.; Takeuchi, S.; Kumada, K. 1998: S-adenosyl-L-methionine attenuates ischemia-reperfusion injury of steatotic livers. Transplantation Proceedings 30(7): 3735-3736

Gomez, A.; Bellido, I.; Fernandez, M.; Sanchez, D.L.C.esta, F. 1996: S-adenosyl-L-methionine diminish alcohol intakes in a chronic alcoholism experimental model in the rat Relationships with -8-hydroxy-2- tetralin binding to rat hippocampus membranes. Methods and Findings in Experimental and Clinical Pharmacology 18(Suppl B): 159

O'donohue, J.W.; Wendon, J.A.; Williams, R. 1996: S-adenosyl-L-methionine in the treatment of cholestasis following acute liver failure A randomised, controlled trial. Gastroenterology 110(4 Suppl): A1282

Pascale, R.M.; Simile, M.M.; De Miglio, M.R.; Nufris, A.; Muroni, M.R.; Daino, L.; Seddaiu, M.A.; Rao, P.M.; Rajalakshmi, S.; Sarma, D.S.R.; Feo, F. 1995: S-adenosyl-L-methionine is a chemopreventive agent for 1,2-dimethylhydrazine -induced hepatocarcinogenesis in orotic acid -promoted rats. Proceedings of the American Association for Cancer Research Annual Meeting 36: 122

Harada, J.; Yoshizawa, N.; Oda, T.; Matsuda, K. 1995: S-adenosyl-L-methionine prevents apoptotic cell death of cerebellar granule neurons. Society for Neuroscience Abstracts 21(1-3): 1305

Cincu, R.; Rodriguez Ortigosa, C.; Quiroga, J.; Prieto, J. 1996: S-adenosyl-L-methionine prevents portal pressure increase and cholestatic effects induced by leukotriene D-4 in rat liver. Journal of Hepatology 25(Suppl 1): 135

Milkiewicz, P.; Ahmed Choudhury, J.; Mills, C.; Elias, E.; Coleman, R. 1998: S-adenosyl-L-methionine protects and reverses tuarolithocholate -induced cholestasis A study in isolated rat hepatocyte couplets. Gastroenterology 114(4 Part 2): A1301

Martin Aurioles, E.; Lopez Egea, M.A.; Luque, M.M.; Gonzalez Correa, J.A.; De La Cruz, J.P.; Sanchez De La Cuesta, F. 1996: S-adenosyl-L-methionine reduces cerebral oxidative stress in cholestasis. Methods and Findings in Experimental and Clinical Pharmacology 18(Suppl B): 164

Concari, M.; Rebecchi, B.; Guicciardi, M.E.; Carubbi, F.; Loria, P.; Fantin, A.M.B.lognani; Carulli, N. 1998: S-adenosyl-L-methionine reduces ethanol-induced mitochondrial toxicity and membrane damage in HEP G2 cells. Journal of Hepatology 28(Suppl 1): 135

Concari, M.; Guicciardi, M.E.; Carubbi, F.; Bozzoli, M.; Tagliazucchi, M.; Crema, G.; Loria, P.; Carulli, N. 1994: S-adenosyl-L-methionine reduces hepatotoxicity induced by hydrophobic bile salts in HepG2 cell line. Journal of Hepatology 21(Suppl 1): S77

Pimenta, M.J.; Kaneta, T.; Larondelle, Y.; Dohmae, N.; Kamiya, Y. 1998: S-adenosyl-L-methionineL-methionine S-methyltranferase from germinating barley. Plant Physiology (Rockville) 118(2): 431-438

Stockand, James D.; Al Baldawi, Nabil F.; Al Khalili, Otor K.; Eaton, Douglas C. 1998: S-adenosyl-homocysteine hydrolase activity modulates aldosterone-induced Na reabsorption. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 46A

Cincu, R.; Rodriguez Ortigosa, C.; Vesperinas, I.; Quiroga, J.; Prieto, J. 1995: S-adenosyl-l-methionine improves cytolysis and cholestasis in leukotriene D-4-induced liver injury. Journal of Hepatology 23(Suppl 1): 167

D.R.cco, A.; Werner, P.; Bottiglieri, T.; Tagliati, M.; Sunkara, M.; Simpson, D. 1997: S-adenosyl-methionine and l-methionine in AIDS-associated vascular myelopathy. Journal of the Neurological Sciences 150(Suppl ): S69

Arias Diaz, J.; Villa, N.; Garcia, C.; Ortiz, P.; Vara, E.; Balibrea, J.L. 1996: S-adenosyl-methionine may protect human isolated hepatocytes from the effects of cytokines. Cell Transplantation 5(5 Suppl 2): 57-61

Vara, E.; Arias-Díaz, J.; García, C.; Villa, N.; Simón, C.; Ortiz, P.; Balibrea, J.L. 1994: S-adenosyl-methionine may protect transplanted hepatocytes against the toxic effects of cytokines. Transplantation Proceedings 26(6): 3364-3366

Vara, E.; Arias Diaz, J.; Garcia, C.; Villa, N.; Simon, C.; Ortiz, P.; Balibrea, J.L. 1994: S-adenosyl-methionine partially prevents the toxic effects of cytokines on isolated hepatocytes. Cell Transplantation 3(3): 225

Matsuda, A.; Shuto, S.; Obara, T.; Shigeta, S.; De Clercq, E. 1996: S-adenosylhomocysteine hydrolase inhibitors as potent anti-RNA viral agents. Antiviral Research 30(1): A54

Shu, S.; Mahadeo, D.C.; Liu, X.; Liu, W.; Parent, C.A.; Korn, E.D. 2006: S-adenosylhomocysteine hydrolase is localized at the front of chemotaxing cells, suggesting a role for transmethylation during migration. Proceedings of the National Academy of Sciences of the United States of America 103(52): 19788-19793

Vartabedian, B.; Blackburn, M.R.; Wakamiya, M.; Kellems, R.E. 1996: S-adenosylhomocysteine hydrolase may be critical to the normal development of the fetal liver. Gastroenterology 110(4 Suppl): A1353

Jeon, B.-G.; Coppola, G.; Perrault, S.D.; Rho, G.-J.; Betts, D.H.; King, W.A. 2008: S-adenosylhomocysteine treatment of adult female fibroblasts alters X-chromosome inactivation and improves in vitro embryo development after somatic cell nuclear transfer. Reproduction 135(6): 815-828

Charlton, C.; Benson, R.; Crowell, B.Jr 1993: S-adenosylmethionine -dependent dopamine metabolites in Parkinsons disease -like abnormal movements. Society for Neuroscience Abstracts 19(1-3): 406

Frey, P.A.; Ballinger, M.D.; Reed, G.H. 1998: S-adenosylmethionine: a 'poor man's coenzyme B12' in the reaction of lysine 2,3-aminomutase. Biochemical Society Transactions 26(3): 304-310

Mita, M.; Yasumasu, I.; Nagahama, Y. 1996: S-adenosylmethionine A possible methyl donor of 1-methyladenine biosynthesis in ovarian follicle cells of the starfish Asterina pectinifera. Zoological Science 13(Suppl ): 70

Chawla, R.K.; Watson, W.H. 1994: S-adenosylmethionine and DNA methylation during oxygen deprivation. FASEB Journal 8(4-5): A942

Choumenkovitch, S.F.; Bagley, P.; Maeda, N.; Nadeau, M.; Smith, D.; Selhub, J. 1998: S-adenosylmethionine and S-adenosylhomocysteine in mice deficient in cystathionine B-synthase. FASEB Journal 12(4): A550

Young, S.N.; Shalchi, M. 1993: S-adenosylmethionine and methionine increase tail-flick latency in rats. Society for Neuroscience Abstracts 19(1-3): 1391

Mato, J.M.; Alvarez, L.; Corrales, F.J.; Pajares, M.A. 1994: S-adenosylmethionine and the liver. Arias, I M The liver: Biology and pathobiology, Third edition 461-470

Turhanowa, L.; Milovic, V.; Bauske, R.; Caspary, S.F.; Stein, J. 1998: S-adenosylmethionine decarboxylase activity is enhanced in colon cancer cells stimulated to grow by epidermal growth factor. Gastroenterology 114(4 Part 2): A693

Thomas, T.; Adhikarakunnathu, S.; Thomas, T.J. 1994: S-adenosylmethionine decarboxylase as a therapeutic target in breast cancer Studies on SAMDC inhibitors in MCF-7 cells. Proceedings of the American Association for Cancer Research Annual Meeting 35: 385

Stanley, B.A.; Shantz, L.M. 1994: S-adenosylmethionine decarboxylase structure-function relationships. Biochemical Society Transactions 22(4): 863-869

Crowell, B.; Charlton, C.; Mack, J.; Sharan, R. 1994: S-adenosylmethionine decreased cerebral tyrosine hydroxylase Relationship to Parkinsons disease associated depression. Society for Neuroscience Abstracts 20(1-2): 414

Chawla, R.; Hill, D.; Watson, B.; Eastin, C.; Mcclain, C.J. 1995: S-adenosylmethionine deficiency and TNF hepatotoxicity. Hepatology 22(4 Part 2): 379A

Watson, W.; Mcclain, C.; Lee, E.; Chawla, R. 1995: S-adenosylmethionine deficiency and alcoholic liver disease Role of tumor necrosis factor-alpha. FASEB Journal 9(4): A870

Watson, W.; Chawla, R. 1996: S-adenosylmethionine deficiency exacerbates tumor necrosis factor -alpha mediated hepatotoxicity. FASEB Journal 10(3): A775

Watson, W.; Chawla, R. 1996: S-adenosylmethionine deficiency may sensitize hepatocytes to tumor necrosis factor-alpha mediated toxicity. Gastroenterology 110(4 Suppl): A1358

Urata, K.; Brault, A.; Huet, P.M. 1997: S-adenosylmethionine does not protect rat livers during extended cold ischemia with or without transplantation. Hepatology 26(4 Part 2): 620A

Rao, A.M.; Baskaya, M.K.; Maley, M.E.; Prasad, R.; Kindy, M.S.; Dempsey, R.J. 1996: S-adenosylmethionine effects on blood-brain barrier breakdown and neuronal cell survival after transient ischemia. Stroke 27(1): 183

Barak, A.J.; Beckenhauer, H.C.; Tuma, D.J. 1994: S-adenosylmethionine generation and prevention of alcoholic fatty liver by betaine. Alcohol 11(6): 501-503

Pavia, J.; Garcia, V.; Garcia, J.J.; Glez Correa, J.A.; De La Cruz, J.P.; Sanchez De La Cuesta, F. 1997: S-adenosylmethionine improves working memory in aged rats. Methods and Findings in Experimental and Clinical Pharmacology 19(Suppl A): 86

Mato, I.M.; Cimara, J.; Ortiz, P.; Rodes, J.; Cirrhosis, S.C.llaborative Group For The Study, O.A.coholic Liver 1997: S-adenosylmethionine in the treatment of alcoholic liver cirrhosis Results from a multicentric, placebo-controlled, randomized, double-blind clinical trial. Hepatology 26(4 Part 2): 251A

Ara, A.I.; Xia, M.; Ramani, K.; Mato, J.é M.; Lu, S.C. 2008: S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation. Hepatology 47(5): 1655-1666

Tchantchou, F.; Graves, M.; Falcone, D.; Shea, T.B. 2008: S-adenosylmethionine mediates glutathione efficacy by increasing glutathione S-transferase activity: implications for S-adenosyl methionine as a neuroprotective dietary supplement. Journal of Alzheimer's Disease: Jad 14(3): 323-328

Lin, S.; Barve, S.; Watson, W.; Chawla, R. 1997: S-adenosylmethionine modulates apoptosis in Jurkat T cells. FASEB Journal 11(3): A384

Watson, W.H.; Chawla, R.K. 1997: S-adenosylmethionine modulates biosynthesis of tumor necrosis factor alpha in murine macrophage cells. Hepatology 26(4 Part 2): 227A

Lan, D.; Lin, S.; Chawla, R. 1998: S-adenosylmethionine modulates expression of IL-2 in Jurkat T-cells. FASEB Journal 12(4): A269

Chawla, R.K.; Watson, W.H.; Eastin, C.E.; Lee, E.Y.; Mcclain, C.J. 1997: S-adenosylmethionine modulates serum TNF concentrations in lipopolysaccharide induced liver injury. Hepatology 26(4 Part 2): 227A

Alvaro, D.; Gigliozzi, A.; Piat, C.; Carli, L.; La Rosa, T.; Bini, A.; Capocaccia, L. 1994: S-adenosylmethionine protects against acute ethanol hepatotoxicity in the isolated perfused rat liver with no effect on transcytosis. Journal of Hepatology 21(Suppl 1): S81

Benz, C.; Breitkreutz, R.; Kloeters Plachky, P.; Rudolph, G.; Sauer, P.; Stremmel, W.; Stiehl, A. 1998: S-adenosylmethionine reduces bile acid-induced apoptosis in primary rat hepatocytes by preventing glutathione depletion. Gastroenterology 114(4 Part 2): A1210-A1211

Mato, J.M.; Alvarez, L.; Ortiz, P.; Pajares, M.A. 1997: S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacology and Therapeutics 73(3): 265-280

Benz, C.; Toex, U.; Kloeters, P.P.; Rudolph, G.; Sauer, P.; Stremmel, W.; Theilmann, L.; Stiehl, A. 1995: S-adenosylmethionine versus ursodeoxycholic acid in bile acid induced liver injury. Hepatology 22(4 Part 2): 395A

Wong, K.K.; Kozarich, J.W. 1994: S-adenosylmethionine-dependent radical formation in anaerobic systems. Sigel, H, Sigel, A Metal Ions in Biological Systems; Metalloenzymes involving amino acid-residue and related radicals 279-313

Charlton, C.G.; Lamango, N. 1997: S-adenosylmethionine-induced tremors and hypokinesia may be related to protein methylation and dopamine depletion, respectively. Society for Neuroscience Abstracts 23(1-2): 1372

Yamaguchi, H.; McCullough, J.R. 1996: S-albuterol exacerbates calcium responses to carbachol in airway smooth muscle cells. Clinical Reviews in Allergy and Immunology 14(1): 47-55

Dini,I.; Tenore,G.C.; Dini,A. 2008: S-alkenyl cysteine sulfoxide and its antioxidant properties from Allium cepa var tropeana seeds. Journal Of Natural Products: 12, 2036-2037

ChenChiuMei; YinMeiChin 2008: S-allyl cysteine, S-ethyl cysteine and S-propyl cysteine alleviate oxidative stress-induced damage within PC12 cells. Journal Of The Science Of Food And Agriculture: 14, 2493-2498

Yamaguchi, K.; Takeda, Y.; Yamada, K.; Tamai, M. 1992: S-antigen in retinas of RCS rat Time course and RPE transplant study. Experimental Eye Research 55(Suppl 1): S251

Zhao, C.; Yang, P.; He, H.; Lin, X.; Li, B.; Zhou, H.; Huang, X.; Kijlstra, A. 2008: S-antigen specific T helper type 1 response is present in Behcet's disease. Molecular Vision 14: 1456-1464

Zhang, J.; Rao, N.A. 1998: S-antigen stimulates expression of INOS and various cytokines in murine macrophages. IOVS Investigative Ophthalmology and Visual Science 39(4): S778

Kang-Sickel, J.-C.C.; Fox, D.D.; Nam, T.-G.; Jayaraj, K.; Ball, L.M.; French, J.E.; Klapper, D.G.; Gold, A.; Nylander-French, L.A. 2008: S-arylcysteine-keratin adducts as biomarkers of human dermal exposure to aromatic hydrocarbons. Chemical Research in Toxicology 21(4): 852-858

Haag Kerwer, A.; Heiss, S.; Schaefer, H.J.; Walter, C.; Rausch, T. 1998: S-assimilation, GSH synthesis and PC formation during Cd-accumulation in Brassica juncea L Linking molecular detoxification mechanisms to the ecophysiological response. Journal of Experimental Botany 49(Suppl ): 24

Procopio, A.; Sindona, G.; Uccella, N. 1993: S-benzyl phosphorodichloridothioate, a versatile agent in the formation of the internucleotidic phosphorothioate linkage. Journal of Chemical Research (Synopses) 1993(1): 16-17

André, G.ël.; Even, S.; Putzer, H.; Burguière, P.; Croux, C.; Danchin, A.; Martin-Verstraete, I.; Soutourina, O. 2008: S-box and T-box riboswitches and antisense RNA control a sulfur metabolic operon of Clostridium acetobutylicum. Nucleic Acids Research 36(18): 5955-5969

Pavlovic, D.; Frieling, H.; Usichenko, T.; Nedeljkov, V.; Nafissi, T.; Lehmann, C.; Aubier, M.; Wendt, M. 2008: S-Carboxymethylcysteine inhibits carbachol-induced constriction of epithelium-denuded rat and human airway preparations. Clinical and Experimental Pharmacology and Physiology 35(5-6): 663-669

Oosterhaven, J.; Hartmans, K.J. 1996: S-carvone inhibits the wound healing of potato tubers temporarily. Plant Physiology (Rockville) 111(2 Suppl): 122

Kamiyama, M.; Yamamoto, S.; Hirata, H. 1995: S-cone ERG in diabetes with and without retinopathy. IOVS Investigative Ophthalmology and Visual Science 36(4): S480

Barnes, C.S.; Shevell, S.K. 1998: S-cone effects on L/M chromatic induction. IOVS Investigative Ophthalmology and Visual Science 39(4): S163

Yamamoto, S.; Hayashi, M.; Takeuchi, S. 1998: S-cone electroretinograms to color flash stimuli in retinitis pigmentosa. IOVS Investigative Ophthalmology and Visual Science 39(4): S969

Mclellan, J.S.; Eskew, R.T.Jr 1997: S-cone increment and decrement detection mechanisms have different long-wavelength inputs. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S891

Mclellan, J.S.; Harrington, K.K.; Eskew, R.T.Jr 1996: S-cone increment and decrement sensitivities differ in transient tritanopia. IOVS Investigative Ophthalmology and Visual Science 37(3): S1062

Reid, R.C.; Alonso, J.M.; Hendry, S.H.C. 1997: S-cone input is relayed to visual cortex from two koniocellular layers of macaque LGN. Society for Neuroscience Abstracts 23(1-2): 13

D.V.lois, R.L.; Cottaris, N.; Elfar, S. 1997: S-cone inputs to striate cortex cells. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S15

Helin, I.; Grubb, A. 1996: S-cystatin C estimates glomerular filtration rate better than S-creatinine. Pediatric Nephrology 10(4): C137

Bontempo, P.; Molinari, A.M.; Mosti, M.R.; Tortora, V.; Armetta, I.; Pezone, L.; Nola, E.; Puca, G.A.; Schiavone, E.M. 1996: S-endo and MUC18 antibodies reactivity on breast cancer cell lines with different invasive properties. Tissue Antigens 48(4-2): 419

Frykman, H.; Ohrner, N.; Norin, T.; Hult, K. 1993: S-ethyl thiooctanoate as acyl donor in lipase catalysed resolution of secondary alcohols. Tetrahedron Letters 34(8): 1367-1370

van Bemmel, D.M.; Visvanathan, K.; Beane Freeman, L.E.; Coble, J.; Hoppin, J.A.; Alavanja, M.C.R. 2008: S-ethyl-N,N-dipropylthiocarbamate exposure and cancer incidence among male pesticide applicators in the agricultural health study: a prospective cohort. Environmental Health Perspectives 116(11): 1541-1546

Garner, A.M.; Solis, C.P.; Kim, K.S. 1996: S-fimbriated E coli cause pial arteriolar injury via the carbohydrate binding specificity of S-fimbriae. Pediatric Research 39(4 Part 2): 295A

Animati, F.; Arcamone, F.; Giannini, G.; Lombardi, P.; Monteagudo, E. 1998: S-fluoro-anthracyclines, processes for their preparation and pharmaceutical compositions containing them. Official Gazette of the United States Patent and Trademark Office Patents 1214(5): 5326

Takasaki-Yasuda,T.; Moriya,Y.; Nakanishi,T.; Iwanami,H.; Bessho,H. 2008: S-genotype assignment of European pear cultivars using S-RNase specific CAPS marker. Acta Horticulturae: 391-400

Levine, R.L.; Cabiscol, E.; Kim, G. 1997: S-glutathiolation regulates the tyrosine phosphatase activity of carbonic anhydrase III. KOREAN SOCIETY OF PHARMACOLOGY Author Symposium on Current Topics in Pharmacology and Toxicology : 50

Reitz, A.B.; Jordan, A.D.; Sanfilippo, P.J.; Scott, M.K.; Vavouyios Smith, A. 1998: S-heteroatom containing alkyl substituted-3-oxo-pyrido- benzimidozole-4-carboxamide derivatives useful in treating central nervous system disorders. Official Gazette of the United States Patent and Trademark Office Patents 1215(1): 590-591

Christensen, M.B. 1996: S-human eosinophil peroxidase and S-eosinophil cationic protein in moderate to severe intrinsic and extrinsic asthma. European Respiratory Journal Suppl 9(23): 119S

Hunter, D.D.; Parisi, M.B.; Meduri, L.; Brunken, W.J. 1994: S-laminin promotes production of the rod photoreceptor phenotype. Society for Neuroscience Abstracts 20(1-2): 655

Mader, C.; Kupcu, S.; Schuster, B.; Sleytr, U.B.; Sara, M. 1998: S-layer proteins, lipids and glycans as basic components to build up supramolecular structures. Abstracts of Papers American Chemical Society 216(1-3): BIOT 192

Rothstein, S.J.; Goring, D. 1998: S-locus receptor kinase gene in a self-incompatible brassica napus line. Official Gazette of the United States Patent and Trademark Office Patents 1215(2): 1790

Moros, C.; Barbanoj, M.J.; Salazar, G.; Morte, A.; Antonijoan, R.M.; Parra, P. 1998: S-mephenytoin hydroxylation phenotypes and benzodiazepine pharmacokinetics after high oral doses Diazepam vs desmethyl-diazepam. Methods and Findings in Experimental and Clinical Pharmacology 20(Suppl A): 56

Gich, I.; Barbanoj, M.J.; Salazar, G.; Antonijoan, R.M.; Ladona, M.; De La Torre, R. 1998: S-mephenytoin hydroxylation phenotypes in subjects living in Barcelona Caucasians vs orientals. Methods and Findings in Experimental and Clinical Pharmacology 20(Suppl A): 54

Sohn, D.R.; Shin, S.; Ishizaki, T. 1994: S-mephenytoin pharmacogenetics and its clinical implications in Asian ethnic populations. Asia Pacific Journal of Pharmacology 9(4): 287-301

Narayanan, K.; Spack, L.; Hayward, M.; Griffith, O.W. 1994: S-methyl-L-thiocitrulline A potent inhibitor of nitric oxide synthase with strong pressor activity in vivo. FASEB Journal 8(4-5): A360

Sandler, S.; Forsbeck, E.; Welsh, N. 1996: S-methyl-L-thiocitrulline protects rat pancreatic islets against interleukin-1-beta induced suppression. Diabetologia 39(Suppl 1): A103

Kengatharan, M.; Szabo, C.; De Kimpe, S.; Southan, G.J.; Thiemermann, C. 1993: S-methyl-isothiourea, a potent inhibitor of the inducible isoform of nitric oxide synthase, has beneficial hemodynamic effects in gram positive and gram negative forms of circulatory shock. FASEB Journal 9(3): A28

Lill, J.S.; Mays, D.C.; Lipsky, J.J. 1996: S-methylation of diethyldithiocarbamate Are rat liver microsomes a good in vitro model for humans. Clinical Pharmacology and Therapeutics 59(2): 171

Nolte, K.D.; Hanson, A.D. 1996: S-methylmethionine is not an intermediate in the biosynthesis of DMSP in Enteromorpha intestinalis. Plant Physiology (Rockville) 111(2 Suppl): 103

Rácz, I.; Páldi, E.; Szalai, G.; Janda, T.; Pál, M.; Lásztity, D. 2008: S-methylmethionine reduces cell membrane damage in higher plants exposed to low-temperature stress. Journal of Plant Physiology 165(14): 1483-1490

Vallotton, N.; Moser, D.; Eggen, R.I.L.; Junghans, M.; Chèvre, N. 2008: S-metolachlor pulse exposure on the alga Scenedesmus vacuolatus: effects during exposure and the subsequent recovery. Chemosphere 73(3): 395-400

Loscalzo, J.; Cooke, J. 1996: S-nitroso derivatives of hydrazinoacetic acids, 1- -1-oxoalkyl-1,2,34-tetrahydroquinoline-2-carboxylic acids and alanyl prolines and isoquinolines. Official Gazette of the United States Patent and Trademark Office Patents 1188(3): 2080

Knott, N.J.; Davies, J.A. 1994: S-nitroso-N-acetyl-penicillamine -induced release of endogenous amino acids from rat striatal slices. British Journal of Pharmacology 114(Proceedings Suppl ): 276P

Lewis, S.J.; Travis, M.D.; Bates, J.N.; Johnson, A.K.; Davisson, R.L. 1996: S-nitrosocysteine receptors in the central nervous system. Hypertension 28(3): 526

Pabelick, C.M.; Perkins, W.J.; Warner, D.O.; Jones, K.A. 1998: S-nitrosoglutathione and calcium sensitivity in airway smooth muscle. Biophysical Journal 74(2 Part 2): A380

Mabley, J.G.; Cunningham, J.M.; Delaney, C.A.; Bolt, S.K.; Schulster, D.; Green, I.C. 1993: S-nitrosoglutathione and hydroxylamine inhibit insulin secretion from rat islets. Diabetologia 36(Suppl 1): A116

Schrammel, A.; Pfeiffer, S.; Koesling, D.; Schmidt, K.; Brunner, F.; Mayer, B. 1997: S-nitrosoglutathione as active intermediate in the stimulation of soluble guanylyl cyclase by the nitrovasodilator SIN-1. Japanese Journal of Pharmacology 75(Suppl 1): 110P

Gaston, B.; Fang, K. 1997: S-nitrosoglutathione breakdown by airway epithelial cells A mechanism for S-nitrosothiol deficiency in the asthmatic airway. Japanese Journal of Pharmacology 75(Suppl 1): 111P

Kalyanaraman, B.; Singh, R.J.t 1998: S-nitrosoglutathione inhibits SOD/H2O2-dependent lipid peroxidation. FASEB Journal 12(5): A1008

Fortenberry, J.D.; Owens, M.; Chen, N.X.; Brown, L.S. 1997: S-nitrosoglutathione inhibits activation of transcription factor NF-kappa-B in human neutrophils. Pediatric Research 41(4 Part 2): 33A

D.B.lder, A.; Salas, E.; Langford, E.; Marrinan, M.; Martin, J.F. 1996: S-nitrosoglutathione inhibits coronary artery vein graft platelet activation in vivo. European Heart Journal 17(ABSTR Suppl ): 545

Langford, E.J.; Salas, E.; Marrinan, M.T.; Martin, J.F.; De Belder, A.J. 1996: S-nitrosoglutathione inhibits platelet activation and deposition in saphenous vein grafts in vitro. European Heart Journal 17(ABSTR Suppl ): 546

Kluge, I.; Gutteck Amsler, U.; Cuenod, M.; Do, K.Q. 1995: S-nitrosoglutathione is endogenous in rat cerebellum. Society for Neuroscience Abstracts 21(1-3): 626

Kalyanaraman, B.; Konorev, E.A.; Joseph, J. 1995: S-nitrosoglutathione monoethyl ester protects the heart during cardioplegic ischemic arrest of isolated rat heart. FASEB Journal 9(4): A922

Vodovotz, Y.; Chan, R.C.; Cook, J.A.; Mitchell, J.B.; Wink, D.; Kim, W.H.; Collins, S.; Seabron, R.; Waksman, R. 1998: S-nitrosoglutathione reduces thrombosis and enhances healing following balloon injury and endovascular radiation of porcine coronary arteries. Circulation 98(17): I113

Molloy, J.; Baskerville, P.A.; Fraser, S.C.; Martin, J.F.; Markus, H.S. 1998: S-nitrosoglutathione, a targeted NO donor, reduces cerebral embolisation in a new in vivo model. Stroke 29(1): 286

Juckett, M.B.; Balla, J.; Weber, M.L.; Peloquin, J.M.; Jacob, H.S.; Vercellotti, G.M. 1993: S-nitrosopencillamine modulates the induction of ferritin by iron in endothelial cells. Clinical Research 41(3): 668A

Fang, K.; Ragsdale, N.V.; Carey, R.M.; Gaston, B. 1997: S-nitrosothiol reduction by vanadium chloride Implications for analysis of biological fluids. Japanese Journal of Pharmacology 75(Suppl 1): 111P

Upchurch, G.R.; Welch, G.N.; Loscalzo, J. 1995: S-nitrosothiols: chemistry, biochemistry, and biological actions. Advances in Pharmacology 34: 343-349

Rauhala, P.; Sziraki, I.; Chiueh, C.C. 1995: S-nitrosothiols SNAP and GSNO inhibit peroxidation of brain lipids in vivo and in vitro. Society for Neuroscience Abstracts 21(1-3): 1252

Khrapova, N.V.; Malenkova, I.V.; Vanin, A.F. 1995: S-nitrosothiols and dinitrosothiol iron complexes as sources of nitric oxide in animal organisms. Biophysics (English Translation of Biofizika) 40(1): 121-126

Barbier, A.J.M.; Lefebvre, R.A. 1994: S-nitrosothiols as relaxant agents in the rat gastric fundus. Moncada, S, Feelisch, M, Busse, B, Higgs, E A Portland Press Proceedings; The biology of nitric oxide, Vol 3 Physiological and clinical aspects 391-394

Stamler, J.; Loscalzo, J.; Slivka, A.; Simon, D.; Brown, R.; Drazen, J. 1995: S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1170(2): 1212

Lewis, S.J.; Shen, J.; Bates, J.N. 1994: S-nitrosothiols augment electron transfer from NAD H to nitroblue tetrazolium. FASEB Journal 8(4-5): A595

Megson, I.L.; Sogo, N.; Campanella, C.; Mazei, F.A.; Butler, A.R.; Webb, D.J. 1998: S-nitrosothiols cause sustained nitric oxide-mediated vasodilation in human saphenous vein Potential as long-term nitric oxide donor drugs in coronary artery bypass grafts. British Journal of Pharmacology 124(Proceedings Suppl ): 16P

Megson, I.L.; Sogo, N.; Mazzei, F.A.; Butler, A.R.; Campanella, C.; Webb, D.J. 1998: S-nitrosothiols cause sustained, nitric oxide mediated vasodilatation in coronary artery bypass grafts. Nitric Oxide 2(5): 303

ZhangHongZhi; GuoXiaoQin; HaoZhongNa; TaoRongXiang 2008: S-nitrosylation a central modification of plant protein. Journal Of Agricultural Biotechnology: 2, 351-356

Xu, L.; Meissner, G.; Eu, P.; Stamler, J.S. 1997: S-nitrosylation activates the cardiac Ca-2+ release channel. Biophysical Journal 72(2 Part 2): A375

Melino, G.; Bernassola, F.; Rossi, A.; Catani, V.; Knight, R.A. 1997: S-nitrosylation of caspases and tissue-transglutaminase regulates death by apoptosis of necrosis. Anticancer Research 17(5C): 3961-3962

Cheung, W.S.; Chen, H.S.V.ncent; Zhang, X.; Lipton, S.A. 1997: S-nitrosylation of putative critical regulatory sulfhydryl group in recombinant cyclic nucleotide-gated channels. Society for Neuroscience Abstracts 23(1-2): 1479

Kjeldsen, J. 1995: S-orosomucoid Improved decision-making for tapering prednisolone in active ulcerative colitis and Crohns disease ?. Gastroenterology 108(4 Suppl): A849

Stevenson, K.S.; Grove, D.S.; Crowl, C.V.; Hamilton, G.A.; Mastro, A.M. 1996: S-oxalins induce apoptosis in thymic lymphoma cells but not in primary thymocytes. Proceedings of the American Association for Cancer Research Annual Meeting 37: 26

Cashman, J.; Park, S. 1993: S-oxidative cleavage of farnesylated cysteines by the flavin-containing monooxygenase. FASEB Journal 7(7): A1040

Gooden, W.E.; Day, R.A.; Kreishman, G.P. 1993: S-peptide and S-protein are covalently linked together through a salt bridge by the action of cyanogen. Protein Engineering 6(Suppl ): 15

Sheykhzade, M.; Smajilovic, S.; Issa, A.; Haunso, S.; Christensen, S.ør.B.øg.; Tfelt-Hansen, J. 2008: S-petasin and butterbur lactones dilate vessels through blockage of voltage gated calcium channels and block DNA synthesis. European Journal of Pharmacology 593(1-3): 79-86

Prosperi, E.; Scovassi, I.; Stivala, L.A.; Bianchi, L. 1993: S-phase PCNA activation is dependent on phosphorylation mechanism. European Journal of Histochemistry 37(Suppl 2): 87

Stewart, E.; Enoch, T. 1996: S-phase and DNA-damage checkpoints: a tale of two yeasts. Current Opinion in Cell Biology 8(6): 781-787

Harbeck, N.; Pache, L.; Schmitt, M.; Dettmar, P.; Jaenicke, F.; Hoefler, H.; Graeff, H. 1994: S-phase and ploidy in primary breast cancer Prognostic impact and correlation to tumor-cell associated proteases. Journal of Cancer Research and Clinical Oncology 120(Suppl ): R17

Ryan, C.A.; Loranger, S.; Allis, C.D.; Annunziato, A.T. 1995: S-phase associated phosphorylation of histone H1 in HeLa cells. Molecular Biology of the Cell 6(Suppl ): 74A

Bodis, S.; Pruschy, M.; Wirbelauer, C.; Glanzmann, C.; Krek, W. 1997: S-phase checkpoint elements of the E2F-1 family increase radiosensitivity in fibrosarcoma cells lacking p53. International Journal of Radiation Oncology Biology Physics 39(2 Suppl): 162

Oelschlaegel, U.; Nowak, R.; Abdul Hamid, G.; Wolf, H.; Jermolow, M. 1992: S-phase detection of immunophenotyped lymphoma cells from the bone marrow with flow-cytometry. Annals of Hematology 65(Suppl ): A100

Mehta, S.; Grimley, P.M. 1995: S-phase enhancement of p53-independent apoptosis induced by staurosporine in human lymphoma cells. Molecular Biology of the Cell 6(Suppl ): 247A

Leng, X.; Connell-Crowley, L.; Goodrich, D.; Harper, J.W. 1997: S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation. Current Biology: Cb 7(9): 709-712

Stal, O.; Skoog, L.; Rutqvist, L.E.; Carstensen, J.; Wingren, S.; Sullivan, S.; Dufmats, M.; Nordenskjold, B. 1994: S-phase fraction and C-erbB-2 expression as predictors of response to adjuvant chemotherapy of breast cancer. Analytical Cellular Pathology 6(3): 226

Ginette, M.; Fawaz, H.; Henry, S.; Sarkis, M. 1996: S-phase fraction and DNA ploidy Useful prognostic markers in stage III malignant melanoma. Proceedings of the American Association for Cancer Research Annual Meeting 37: 195

Harbeck, N.; Schueren, E.; Pache, L.; Schmitt, M.; Jaenicke, F.; Dettmar, P.; Hoefler, H.; Graeff, H. 1992: S-phase fraction and ploidy as prognostic factors in primary breast cancer and their correlation to tumor-cell associated proteases. Breast Cancer Research and Treatment 23(1-2): 149

Steinhoff, M.M.; Falkenberry, S.S. 1996: S-phase fraction in endometrial biopsies predicts depth of myometrial invasion of endometrial carcinomas. Modern Pathology 9(1): 98A

Kupryjanczyk, J.; Edgerton, S.; Effird, J.; Yandell, D.; Thor, A. 1995: S-phase fraction in gynecologic cancers A comparison with p53 accumulation and p53 gene mutation. Pathology Research and Practice 191(7-8): 705

Colloby, P.S.; Pringle, J.H.; Fletcher, A.; Hemming, D.; Healsmith, M.; Graham Brown, R.; West, K.P.; Lauder, I. 1993: S-phase fraction in melanocytic proliferations demonstrated by non-isotopic in situ hybridisation for histone mRNAs in paraffin embedded tissue. Journal of Pathology 169(Suppl): 158A

Harbeck, N.; Schueren, E.; Ziffer, P.; Pache, L.; Schmitt, M.; Thomssen, C.; Jaenicke, F.; Dettmar, P.; Nathrath, W.; Graeff, H. 1994: S-phase fraction is a significant prognostic factor in node-negative breast cancer. Breast Cancer Research and Treatment 32(Suppl ): 54

Harbeck, N.; Dettmar, P.; Thomssen, C.; Pache, L.; Schmitt, M.; Jaenicke, F.; Nathrath, W.; Graeff, H. 1996: S-phase fraction is a stronger prognostic factor in node-negative breast cancer than MIB1 proliferation rate. Breast Cancer Research and Treatment 37(Suppl ): 58

Kolfschoten, I.; Hulscher, S.; Schluper, H.; Scheffer, P.J.; Pinedo, H.M.; Boven, E. 1998: S-phase fraction is most predictive for chemosensitivity as determined in 15 human ovarian cancer xenografts. Proceedings of the American Association for Cancer Research Annual Meeting 39: 56

Wingren, S.; Stal, O.; Brisfors, A.; Sullivan, S.; Nordenskjold, B. 1994: S-phase fraction of cytokeratin containing breast cancer cells improves the prediction of recurrence. Analytical Cellular Pathology 6(3): 225-226

Remvikos, Y.; Mosseri, V.; Asselain, B.; Fourquet, A.; Durand, J.C.; Pouillart, P.; Magdelena, H. 1993: S-phase fractions of breast cancer Interaction with treatment and prognosis. Breast Cancer Research and Treatment 27(1-2): 138

Banerjee, D.; Harris, P.; Taylor, M. 1997: S-phase fractions of non-neoplastic lymphocytes parallel those of neoplastic cells in intermediate and high grade non-Hodgkins lymphomas. Clinical and Investigative Medicine 20(4 Suppl): S69

Kireeva, S.S.; Shimanskaya, R.B. 1995: S-phase frequency cells and cells with micronuclei as predictive values of oral and oropharyngeal squamous cell carcinoma response to treatment. Pathology Research and Practice 191(7-8): 696

Sasaki, K.; Uehara, M. 1993: S-phase lymphocytes of peripheral blood in patients with autosensitization dermatitis. Journal of Investigative Dermatology 101(3): 447

Kill, I.R.; Hutchison, C.J. 1994: S-phase modification of lamin B following serum restimulation of quiescent human dermal fibroblasts. Journal of Cellular Biochemistry Suppl 1994(18C): 94

Wnuk, S.F.; Lalama, J.; Garmendia, C.A.; Robert, J.; Zhu, J.; Pei, D. 2008: S-Ribosylhomocysteine analogues with the carbon-5 and sulfur atoms replaced by a vinyl or (fluoro)vinyl unit. Bioorganic and Medicinal Chemistry 16(9): 5090-5102

Smith, C.S. 1997: S-shaped electrotherapy massage stick. Official Gazette of the United States Patent and Trademark Office Patents 1203(1): 299

Witczak, Z.J. 1998: S-thiodisaccharides as alpha-L-fucosidase inhibitors. Abstracts of Papers American Chemical Society 215(1-2): CARB 61

Eaton, P.; Hearse, D.J.; Shattock, M.J. 1998: S-thiolation of the alpha1 catalytic but not the beta1 regulatory subunit of the Na/K ATPase during early cardiac repefusion. Circulation 98(17): I805

Peralampi, M. 1996: S-timolol hemihydrate composition and method of preparation therefor. Official Gazette of the United States Patent and Trademark Office Patents 1192(2): 1254

Peralampi, M. 1996: S-timolol hemihydrate treatment process. Official Gazette of the United States Patent and Trademark Office Patents 1188(5): 3708

Liu, Z.; Zai, A.; Scribner, A.W.; Loscalzo, J. 1997: S-transnitrosation reactions involving plasma membrane thiol groups are mechanistic determinants of the biological effects of S-nitrosothiols. Circulation 96(8): I675-I676, 10-21/97

Radosevich, M.; Tuovinen, O.H.; Traina, S.J. 1995: S-triazine degrading bacteria. Official Gazette of the United States Patent and Trademark Office Patents 1176(1): 370

Kobayashi, H.; Komatsu, T.; Fukuda, S.; Tsuchida, Y.; Kato, M.; Yaguchi, S.; Ogose, N.; Ono, H.; Izumisawa, Y.; Takahashi, M.; Nakagane, T. 1996: S-triazine derivative and remedy for estrogen-dependent disease containing said derivative as effective component. Official Gazette of the United States Patent and Trademark Office Patents 1183(1): 280

Walzel, H.; Neels, P.; Neebe, B.; Brock, J. 1994: S-type lectin-mediated effects on intracellular calcium concentration of T-cells. Biological Chemistry Hoppe-Seyler 375(SPEC Suppl 1): S106

Liu, F.T. 1993: S-type mammalian lectins in allergic inflammation. Immunology Today 14(10): 486-490

Abernethy, D.R.; Wainer, I.W.; Longstreth, J.A.; Searle, G.D. 1993: S-verapamil pharmacodynamics in aging. Clinical Pharmacology and Therapeutics 53(2): 194

Schutz, R.; Josic, D.; Kerner, B.; Schwartz, D.W.M.; Mayr, W.R. 1998: S/D-treated FFP from prestorage inline filtered whole blood. Vox Sanguinis 74(Suppl 1): 1299

Stickeler, E.; Medina, D.; Berget, S.M. 1998: S/R protein expression patterns reflect stages of breast cancer tumorigenesis and affect alternative splicing of CD44. Proceedings of the American Association for Cancer Research Annual Meeting 39: 257

Bernard, G.; Breittmayer, J.P.; Ticchioni, M.; Vivinus, M.; Bernard, A. 1993: S087 and S109 monoclonal antibodies against cell adhesion molecules induce a strong aggregation of human thymocytes. Tissue Antigens 42(4): 260

Badu-Apraku,B.; Fakorede,M.A.B.; Lum,A.F. 2008: S1 family selection in early-maturing maize populations in Striga-infested and Striga-free environments. Crop Science: 5, -1994

BingGuoXia; LiuXiang; LiuJinHua; WuQingMin 2008: S1 gene sequence analysis of a kidney diseases strain of avian infectious bronchitis virus. Chinese Journal Of Veterinary Medicine: 5, 16-18

Lefebvre, L.; Viville, S. 1998: S1 nuclease analysis of RNA. Rapley, R, Walker, J M Molecular biomethods handbook 35-49

Cammas, F.M.; Clark, A.J. 1996: S1 nuclease protection assay using streptavidin dynabeads-purified single-stranded DNA. Analytical Biochemistry 236(1): 182-184

Louie, P.; Kim M H.; Nakayama, R.; Holten, D. 1990: S1 nuclease quantitation of glucose 6 phosphate dehydrogenase messenger rna. FASEB Journal 4(7): A1023

Katoh, T.; Mimuro, M. 1992: S1 state of fucoxanthin involved in energy transfer to chlorophyll a in the light-harvesting proteins of brown algae. Murata, N Research in photosynthesis, Vol 1; IXth International Congress on Photosynthesis: 227-230

Numakura, K.; Kato, M.; Totsuka, S.; Yamamoto, T. 1996: S1-S2+R, S1+R-S2+R paradigm and schizophrenia. Ogura, C, Koga, Y, Shimokochi, M International Congress Series; Recent advances in event-related brain potential research 905-907

Moraczewska, J.; Hitchcock Degregori, S.E. 1998: S1-induced actin binding of tropomyosin depends on its C-terminus. Biophysical Journal 74(2 Part 2): A53

Prochniewicz, E.; Thomas, D.D. 1997: S1-induced changes in the microsecond dynamics of actin are mimicked by other modifications of myosin binding sites. Biophysical Journal 72(2 Part 2): A387

Wang, Z.Y.; Deuel, T.F. 1996: S1-nuclease-sensitive DNA structures contribute to transcriptional regulation of the human PDGF A-chain. Progress in Nucleic Acid Research and Molecular Biology 55: 227-244

Brenner, W.; Hauschild, A.; Engel, G.; Bohuslavizki, K.H.; Moenig, H.; Christophers, E.; Henze, E. 1997: S100 IRMA A new and prognostic tumor marker in patients with malignant melanoma. Journal of Nuclear Medicine 38(5 Suppl): 148P

Geczy, C.L. 1994: S100 Proteins in inflammation. Journal of Cellular Biochemistry Suppl 1994(18 Part A): 267

Zimmer, D.B. 1989: S100 alpha and s100 alpha binding proteins in adult and developing rat skeletal muscles. Journal of Cell Biology 109(4 Part 2): 263A

Chessher, J.; Gardner, N.; Schaffer, S.; Wilson, G.; Zimmer, W.E.; Zimmer, D.B. 1995: S100 and calmodulin expression in diabetes. Society for Neuroscience Abstracts 21(1-3): 1532

Bledsoe, S.; Zhou, F.C. 1992: S100 and ontogenesis of radial glia-like cells and astrocytes during development of rat brain. Society for Neuroscience Abstracts 18(1-2): 1117

Otto, M.; Wiltfang, J.; Tumani, H.; Zerr, I.; Poser, S. 1997: S100 as a tumor marker in neurological diseases. Anticancer Research 17(6C): 4236-4237

Barger, S.W.; Van Eldik, L.J. 1991: S100 beta a growth factor with neurotrophic activity stimulates increases in intracellular calcium in neuronal and glial cells. Society for Neuroscience Abstracts 17(1-2): 1500

Marshak, D.R. 1990: S100 beta as a neurotrophic factor. Progress in Brain Research 86: 169-181

Griffin, W.S.T.; Stanley, L.C.; Mrak, R.E.; Perrot, L.J. 1991: S100 beta is elevated in brain cells of aids patients. Society for Neuroscience Abstracts 17(1-2): 1273

Barger, S.W.; Selinfreund, R.H.; Eldik, L.J.V. 1990: S100 beta stimulates glial cell proliferation. Journal of Cell Biology 111(5 Part 2): 227A

Wei, N.; Tahan, S.R. 1998: S100+ cell response to squamous cell carcinoma of the lip: inverse correlation with metastasis. Journal of Cutaneous Pathology 25(9): 463-468

Taskin, M.R.H.da; Santagada, E.; Ioachim, H.I. 1996: S100 may identify granulomas of Mycobacterium avium intracellulare. Modern Pathology 9(1): 132A

Hanson, C.A.; Remick, D.G.; Fox, D.A.; Bockenstedt, P.L.; Schnitzer, B. 1989: S100 positive chronic lymphoproliferative disease association with natural killer nk cell expression and function. Laboratory Investigation 60(1): 37A

Kindel, S.E.; Walton, R.; Smoller, B.R. 1992: S100 positive histiocytic proliferations mimicking malignant melanoma. Journal of Cutaneous Pathology 19(6): 532

Bossart, E.; Biedler, J.L. 1990: S100 protein a potential marker of human neuroblastoma n s lineage specific cell differentiation. Anticancer Research 10(5 Part B): 1398

Marks, A.; Allore, R. 1990: S100 protein and down syndrome. Bioessays: News and Reviews in Molecular Cellular and Developmental Biology 12(8): 381-383

Kaehn, G.; Kasel, P.; Nolte, A.; Peter, R.U. 1997: S100 protein in peripheral blood as a tumour marker in malignant melanoma. Melanoma Research 7(2): 168

Pillay, N.S.; Asplin, J.R.; Coe, F.L. 1995: S100 protein inhibits aggregation and growth of calcium oxalate monohydrate crystals, and is likely to be of physiological significance in urine. Journal of the American Society of Nephrology 6(3): 953

Skelton, H.G.; Smith, K.J.; Barrett, T.L.; Lupton, G.P. 1991: S100 protein staining in cellular blue nevi. Journal of Cutaneous Pathology 18(5): 390

Kirk, W.; Nyitrai, M.; Prendergast, F. 1997: S100 protein-ligand interactions Calorimetric and fluorescence studies. Biophysical Journal 72(2 Part 2): A87

Motoi, M.; Kitamura, Y.; Kato, M.; Akiyoshi, H.; Ichihara, K.; Nakamoto, S.; Yoshino, T.; Takahashi, K.; Akagi, T. 1992: S100 protein-positive T-cell lymphoma Report of three cases. Yonago Acta Medica 35(2): 127-132

Wicki, R.; Schafer, B.W.; Heizmann, C.W. 1996: S100 proteins are transcriptionally regulated by differential DNA methylation in human tumors. Experientia 52(ABSTR ): A59

Parikh, H.N.; Krishnan, V.; Pingerelli, P.L.; Mizukami, H. 1993: S100 proteins as an activator of cyclic nucleotide phosphodiesterase. Biophysical Journal 64(2 Part 2): A100

Hu, J.; Guevara, J.; Van Eldik, L.J. 1995: S100-beta Activates inducible nitric oxide synthase in rat cortical astrocytes. Society for Neuroscience Abstracts 21(1-3): 565

Li, Y.K.; Wong, J.Z.; Sheng, J.G.; Jones, R.A.; Mrak, R.E.; Griffin, W.S.T. 1997: S100-beta increases beta-amyloid precursor protein mRNA levels in rat neuronal cultures. Society for Neuroscience Abstracts 23(1-2): 1651

Wilder, P.T.; Weber, D.J. 1996: S100-beta inhibition of PKC-alpha and PKM phosphorylation of a synthetic peptide derived from p53. Biophysical Journal 70(2 Part 2): A62

Okazaki, K.; Obata, N.H.; Inoue, S.; Hidaka, H. 1995: S100-beta is a target protein of neurocalcin delta, an isoform abundant in glial cells. Biophysical Journal 68(2 Part 2): A384

Sheng, J.G.; Mrak, R.E.; Griffin, W.S.T. 1995: S100-beta protein and mRNA expression is increased with advancing age in human brain Implications for understanding early events in Alzheimer pathogenesis. Journal of Neurochemistry 64(Suppl 1): S6

Mcadory, B.S.; Knapp, J.; Van Eldik, L.J.; Norden, J.J. 1996: S100-beta protein expression is correlated with axonal outgrowth. Society for Neuroscience Abstracts 22(1-3): 1969

Yuan, Y.; Parikh, H.; Krishnan, V.; Mizukami, H. 1995: S100A and S100B proteins activate cyclic nucleotide phosphodiesterase in a calcium dependent manner. Biophysical Journal 68(2 Part 2): A202

Zimmer, D.B. 1997: S100A1 A link between paired helical filaments and A-beta?. Society for Neuroscience Abstracts 23(1-2): 840

Pula, G.; Donato, R. 1998: S100A1/B inhibits IL-2-induced proliferation and IFNgamma secretion in a cytotoxic T cell. FASEB Journal 12(5): A928

Lloyd, B.H.; Ruddell, C.; Rudland, P.S.; Barraclough, R. 1996: S100A3 mRNA expression displays an inverse correlation to breast cancer progression. Biochemical Society Transactions 24(3): 340s

Takizawa, T.; Takizawa, T.; Kizawa, K.; Uchiwa, H.; Arai, S.; Saito, T. 1996: S100A3, a cysteine-rich calcium-binding protein, is highly expressed in the human hair shaft. Molecular Biology of the Cell 7(Suppl ): 139A

Schneider, M.; Hansen, J.L.; Sheikh, S.ør.P. 2008: S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases?. Journal of Molecular Medicine 86(5): 507-522

Boyd, J.H.; Kan, B.; Roberts, H.; Wang, Y.; Walley, K.R. 2008: S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circulation Research 102(10): 1239-1246

Huang-Daifa; Fu-Weineng; Guo-Yan; Xu-Zhenming; Sun-Xinghe; Sun-Kailai 2008: S100A8 mediates the activation of P65/HLA-B/S100A8/BCL-2/Caspase-9 -3 pathway in laryngeal carcinogenesis. Chinese Science Bulletin 53(13): 2017-2024

Nukui, T.; Ehama, R.; Sakaguchi, M.; Sonegawa, H.; Katagiri, C.; Hibino, T.; Huh, N-Ho. 2008: S100A8/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes. Journal of Cellular Biochemistry 104(2): 453-464

Esposito, G.; Scuderi, C.; Lu, J.; Savani, C.; De Filippis, D.; Iuvone, T.; Steardo, L.; Sheen, V.; Steardo, L. 2008: S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells. Journal of Cellular and Molecular Medicine 12(3): 914-927

Drohat, A.C.; Nenortas, E.; Beckett, D.; Weber, D.J. 1997: S100B oligomerization state at nanomolar concentration. Biophysical Journal 72(2 Part 2): A80

Nigro, F.; Gagliardi, L.; Ciotti, S.; Galvano, F.; Pietri, A.; Tina, G.L.; Cavallaro, D.; La Fauci, L.; Iacopino, L.; Bognanno, M.; Li Volti, G.; Scacco, A.; Michetti, F.; Gazzolo, D. 2008: S100B Protein concentration in milk-formulas for preterm and term infants. Correlation with industrial preparation procedures. Molecular Nutrition and Food Research 52(5): 609-613

Robinson, N.A.; Lapic, S.; Welter, J.F.; Eckert, R.L. 1997: S100C, S100A10, annexin 1, desmosomal proteins, SPRs, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes. Journal of Investigative Dermatology 108(4): 553

Mariggio' M.A.; Antonica, A.; Fulle, S.; Pagliacci, M.C.; Nicoletti, I.; Fano' G. 1991: S100ab increases cell death in pc12. European Journal of Cell Biology Suppl (35): 45

Yoshino, T.; Takahashi, K.; Akagi, T. 1990: S100b positive t cell lymphoma leukemia a new type of suppressor cytotoxic s c t cell malignancy. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 320

Hansson, L.O.; Djuren, E.; Dijlai Merzog, R.; Nilsson, B.; Hansson, J. 1997: S100beta A prognostic marker in malignant melanoma. Anticancer Research 17(6C): 4207

Griffin, W.S.T.; Graham, D.I.; Mckenzie, J.E.; Royston, M.C.; Mrak, R.E.; Gentleman, S.M. 1998: S100beta immunoreactivity following fatal head injury. Journal of Neurotrauma 15(1): 52

Li, Y.; Barger, S.W.; Liu, L.; Mrak, R.E.; Griffin, W.S.T. 1998: S100beta induces neuronal IL-6 expression Implications for Alzheimer pathogenesis. Society for Neuroscience Abstracts 24(1-2): 2136

Domowicz, M.; Mangoura, D.; Li, H.; Sakellaridis, N.; Schwartz, N.B. 1994: S103L neuronal proteoglycan in development Assembly and function. Society for Neuroscience Abstracts 20(1-2): 1494

Krueger, R.C.; Schwartz, N.B. 1994: S103L-reactive chondroitin sulfate proteoglycan in neuronal migration. Pediatric Research 37(4 Part 2): 381A

Ferguson, S.E.; Osborne, B.A.; Cancro, M.P. 1989: S107 v h characterization of a mouse exhibiting low responsiveness to phosphorylcholine. Journal of Cellular Biochemistry Suppl (13 Part C): 69

Loos, U.; Clement, J.; Hausdorf, S. 1989: S14 a novel differentiation dependent gene product in 3t3 l1 adipocytes. Journal of Cellular Biochemistry Suppl (13 Part E): 238

Marcellán, O.N.; Acevedo, A.; Camadro, E.L. 2006: S16, a novel S-RNase allele in the diploid species Solanum chacoense. Genome 49(8): 1052-1054

Janiak, P.; Thurieau, C.; Pillon, A.; Fauchere, J.L.; Vilaine, J.P. 1994: S16077, a new somatostatin analogue, inhibits neointima formation induced by balloon injury in rats and rabbits without altering growth hormone release. European Heart Journal 15(ABSTR Suppl ): 318

Petitte, D.; Dorshkind, K.; Narayanan, R.; Guappone, A.; Chiu C P.; Landreth, K.S. 1992: S17 stromal cells il 7 and kit ligand regulate pre b cell proliferation. Experimental Hematology (Charlottesville) 20(1): 106

Van Lijsebettens, M.; Vanderhaeghen, R.; De Block, M.; Bauw, G.; Villaroel, R.; De Bleeckere, M.; Van Montagu, M. 1995: S18 ribosomal protein and plant development in Arabidopsis. Mededelingen van de Faculteit Landbouwwetenschappen - Rijksuniversiteit Gent 60(4A-B): 1643-1650

Lippa, Carol F.; Fraser, P.E.; Nee, L.; Alexander, M.; Salo, D.; St George Hyslop, P. 1996: S182 and E5-1 immunoexpression in normal aging and Alzheimers disease. Neurology 46(2 Suppl): A275

Higuchi, S.; Matsushita, S.; Hasegawa, Y.; Muramatsu, T.; Itabashi, S.; Arai, H. 1996: S182 and STM2 gene missense mutations in sporadic Alzheimer disease. American Journal of Medical Genetics 67(4): 429

Schemchel, D.; Stopa, E.G.; Rubin, B.S.; Kuo Leblanc, V.; Song, P.C.; King, J.C.; Boteva, K.; Mitsuda, N.; Gilbert, J.R.; Vitek, M.P. 1996: S182/presenilin-1 protein and mRNA in AD. Society for Neuroscience Abstracts 22(1-3): 727

Devine, K.M.; Smicun, Y.; Hope, J.Mayer.; Fishman, D.A. 2008: S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac. Gynecologic Oncology 110(2): 237-245

Means, C.Kable.; Miyamoto, S.; Chun, J.; Brown, J.Heller. 2008: S1P1 receptor localization confers selectivity for Gi-mediated cAMP and contractile responses. Journal of Biological Chemistry 283(18): 11954-11963

Rodriguez Ferrer, C.R.; Muros, D.F.entes, M.; Perez, H.; Oaknin, S. 1996: S2 allele of apopoprotein as a predictor of premature coronary heart disease. Journal of Physiology (Cambridge) 493P: 79S-80S

Vincent, S.; Marty, L.; Fort, P. 1993: S26 ribosomal protein RNA: an invariant control for gene regulation experiments in eucaryotic cells and tissues. Nucleic Acids Research 21(6): 1498

Mannuzzu, L.M.; Moronne, M.M.; Isacoff, E.Y. 1996: S4 movement correlates with gating charge displacement during Shaker channel gating. Biophysical Journal 70(2 Part 2): A406

Groome, J.; Fujimoto, E.; Olsen, J.; George, A.L.Jr.; Ruben, P.C. 1998: S4 translocation during sodium channel deactivation is an ordered process. Biophysical Journal 74(2 Part 2): A401

Horie, K.; Bell, K.; Hughes, R.J.; Insel, P.A. 1998: S49 lymphoma cells express multiple G-coupled-receptor kinases. FASEB Journal 12(4): A449

Anderson, K.; Hughes, R.J.; Insel, P.A. 1993: S49 mouse lymphoma cells express exclusively the beta-ARK-1 gene. FASEB Journal 7(7): A1113

Kawarada, Y.; Tabata, M.; Yamagiwa, K.; Taoka, H.; Isaji, S.; Yokoi, H.; Ogura, Y.; Noguchi, T. 1998: S4b+S5-Resection with total caudate lobectomy using Taj Mahal liver incision for carcinoma of the biliary tract. Gastroenterology 114(4 Part 2): A1400

Harris, R.C. 1990: S6 kinase activity increases in cultured proximal tubule cells with epidermal growth factor egf and insulin and in renal cortex after uninephrectomy unx. Kidney International 37(1): 195

Yang, Z.; Julmy, F.; Luescher, T.F. 1994: S6 kinase and mitogen-activated protein kinase mediate proliferation in response to platelet-derived growth factor in human smooth muscle cells Effects of transforming growth factor beta-1 and calcium antagonists. Circulation 90(4 Part 2): I191

Yang, Z.; Luscher, T.F. 1994: S6 kinase mediates human smooth muscle cell growth to platelet-derived growth factor Lack of inhibition by transforming growth factor beta-1 and Ca-2+ antagonists. European Heart Journal 15(ABSTR Suppl ): 116

Kyriakis, J.M.; Avruch, J. 1994: S6 kinases and MAP kinases Sequential intermediates in insulin/mitogen-activated protein kinase cascades. Woodgett, J R Frontiers in Molecular Biology; Protein kinases 85-148

Vik, T.A.; Crews, C.M.; Calvo, V.; Bierer, B.E. 1992: S6 kinases in models of t cell receptor activation and proliferation. Journal of Cellular Biochemistry Suppl (16 Part C): 81

Ferrari, S.; Thomas, G. 1994: S6 phosphorylation and the p70s6k/p85s6k. Critical Reviews in Biochemistry and Molecular Biology 29(6): 385-413

Elliott, B.M. 1991: S9 preparation and the relevance of enzyme diversity. Mutagenesis 6(5): 438

Galloway, S.M.; Armstrong, M.J.; Bean, C.L.; Hammermeister, C.L.; Johnson, T.E.; Stallworth, M.V. 1990: S9 treatment conditions for in vitro cytogenetic assays. Environmental and Molecular Mutagenesis Suppl 15(17): 20

Yang H M.; Lund, T.; Niebuhr, E.; Shen, L. 1989: S9 y a subclone from s21 not detecting a 10 kb constant band. Cytogenetics and Cell Genetics 51(1-4): 1112-1113

Reuter, K.; Ficner, R.; Garcia, G.A.; Kersten, H. 1994: S90 of the E coli tRNA guanine transglycosylase is important for enzymic activity and conserved in the corresponding Zymomonas mobilis enzyme. Biological Chemistry Hoppe-Seyler 375(SPEC Suppl 1): S85

Mazier, B.; Berlion, M.; Lucas, C.; Paraire, M.; Berille, J.; Giroux, B.; Gerard, B.; Sarkany, M.; Bizzari, J.P. 1993: S9788 Multidrug resistance modulator. Drugs of the Future 18(8): 711-713

Poupon, M.F.; Berlion, M.; Atassi, G.; Dunn, T.; Bizzari, J.P. 1992: S9788 a new resistance modulator enhances the antitumoral activity of vepeside cisplatinum treatment on a p glycoprotein positive small cell lung cancer xenograft. Proceedings of the American Association for Cancer Research Annual Meeting 33: 468

Merlin, J.L.; Marchal, S.; Ramacci, C.; Poullain, M.G.; Paraire, M.; Lucas, C. 1995: S9788 modulates nuclear distribution of daunorubicin in multidrug resistant cells. Proceedings of the American Association for Cancer Research Annual Meeting 36: 370

Gibassier, J.; Lucas, C.; Raoul, M.L.; Denais, A.; Darcel, F.; Massart, C. 1996: S9788 reverses in vitro and in vivo the doxorubicin-induced toxicity in a human medullary thyroid carcinoma cell line. Cell Biology and Toxicology 12(4-6): 388

Rossi, J.F.; Pascal, P.; Pinguet, F.; Fabbro, M.; Legouffe, E.; Berger, E.; Giroux, B. 1994: S9788, an effective new compound for P-glycoprotein-multidrug resistance modulation in non Hodgkins lymphoma when associated to doxorubicin Preliminary results of biologic assays and phase I-II study. Blood 84(10 Suppl 1): 647A

D.S.uza, A.C.; Akhtar, R.P.; Reek, C.; Spyt, T.J. 1995: SA and AV node ischaemia, a possible cause of post-CABG atrial fibrillation?. Clinical Science 88(2): 24P

Yang, T.; Hassan, S.A.; Singh, I.; Smart, A.; Brosius, F.C.; Schnermann, J.B.; Briggs, J.P. 1995: SA gene mRNA expression in kidney is localized to the proximal convoluted tubule. Hypertension 26(3): 547

Yang, T.; Hassan, S.A.; Singh, I.; Smart, A.; Brosius, F.C.; Schnermann, J.B.; Briggs, J.P. 1995: SA gene mRNA expression in kidney is localized to the proximal tubule. Journal of the American Society of Nephrology 6(3): 636

Murai, M.; Tsuji, F.; Nose, M.; Seki, I.; Oki, K.; Setoguchi, C.; Suhara, H.; Sasano, M.; Aono, H. 2008: SA13353 (1-[2-(1-Adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)propyl]urea) inhibits TNF-alpha production through the activation of capsaicin-sensitive afferent neurons mediated via transient receptor potential vanilloid 1 in vivo. European Journal of Pharmacology 588(2-3): 309-315

Matsuno, K.; Mita, S. 1998: SA4503 A novel sigma1 receptor agonist. CNS Drug Reviews 4(1): 1-24

Arnon, R. 1996: SA7, SA12, SA31, and SA48 Antigen AChE. Hybridoma 15(1): 97

Scheinberg, M.A.; Mota, I.M.; Huebscher, O. 1992: SAA amyloid protein and interleukin-6 in juvenile rheumatoid arthritis A cooperative study. Arthritis and Rheumatism 35(9 Suppl): S329

De Beer, Frederick C.; Connell, Patrice M.; De Beer, Maria C.; Webb, Nancy R.; Van Der Westhuyzen, Deneys R. 1998: SAA and sPLA2 modification of HDL influences SR-BI mediated lipid flow. Circulation 98(17): I202

Young, A.D.; Ancsin, J.B.; Bagshaw, W.; Kisilevsky, R. 1995: SAA inhibits HDL-cholesterol uptake from LDL/LDL-an additional clue to its principal function. Modern Pathology 8(1): 37A

Brogden, K.A.; Ackermann, M.; Huttner, K.M. 1998: SAAP, antimicrobial peptides, are found in ovine bronchoalveolar lavage fluid and respiratory epithelium. Abstracts of the General Meeting of the American Society for Microbiology 98: 252

Helas, G.; Andreae, M.O.; Schebeske, G.; Lecanut, P. 1995: SAARI-94 A preliminary view of results. South African Journal of Science 91(7): 360-362

Vasconcelos,M.J.V.de; Fontes,M.A.; Paiva,E.; Carvalho,C.H.S.de; Barbosa,S.M. 2008: SAAT sonicated assisted Agrobacterium-mediated transformation of tropical maize embryos. Revista Brasileira De Milho E Sorgo: 2, 105-112

Maupetit, J.; Gautier, R.; Tufféry, P. 2006: SABBAC: online Structural Alphabet-based protein BackBone reconstruction from Alpha-Carbon trace. Nucleic Acids Research 34(Web Server Issue): W147-W151